Transactivation	O
of	O
the	O
interleukin-1alpha	B-DNA
promoter	I-DNA
by	O
human	B-protein
T-cell	I-protein
leukemia	I-protein
virus	I-protein
type	I-protein
I	I-protein
and	I-protein
type	I-protein
II	I-protein
Tax	I-protein
proteins	I-protein
.	O

Human	B-cell_line
T-cell	I-cell_line
leukemia	I-cell_line
virus	I-cell_line
type	I-cell_line
I	I-cell_line
(	I-cell_line
HTLV-I	I-cell_line
)	I-cell_line
-infected	I-cell_line
T-cell	I-cell_line
lines	I-cell_line
constitutively	O
produce	O
high	O
levels	O
of	O
interleukin-1alpha	B-protein
(	O
IL-1alpha	B-protein
)	O
.	O

To	O
analyze	O
the	O
mechanisms	O
that	O
lead	O
to	O
the	O
expression	O
of	O
IL-1alpha	B-protein
in	O
HTLV-I-infected	B-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
we	O
studied	O
regulatory	O
regions	O
of	O
the	O
human	O
IL-1alpha	B-DNA
promoter	I-DNA
involved	O
in	O
activation	O
of	O
the	O
IL-1alpha	B-DNA
gene	I-DNA
.	O

IL-1alpha	B-DNA
promoter	I-DNA
constructs	I-DNA
drive	O
transcription	O
of	O
the	O
chloramphenicol	B-DNA
acetyltransferase	I-DNA
(	I-DNA
CAT	I-DNA
)	I-DNA
reporter	I-DNA
gene	I-DNA
in	O
HTLV-I-positive	B-cell_line
MT-2	I-cell_line
cells	I-cell_line
,	O
which	O
constitutively	O
produce	O
IL-1alpha	B-protein
.	O

In	O
a	O
cotransfection	O
assay	O
,	O
the	O
Tax	B-protein
protein	I-protein
of	O
both	O
HTLV-I	O
and	O
HTLV-II	O
specifically	O
activated	O
transcription	O
from	O
the	O
IL-1alpha	B-DNA
promoter	I-DNA
in	O
an	O
uninfected	B-cell_line
Jurkat	I-cell_line
cell	I-cell_line
line	I-cell_line
.	O

A	O
mutant	O
Tax	B-protein
protein	I-protein
deficient	O
in	O
transactivation	O
of	O
genes	O
by	O
the	O
nuclear	B-protein
factor	I-protein
(	I-protein
NF	I-protein
)	I-protein
-kappaB	I-protein
pathway	O
was	O
unable	O
to	O
induce	O
transcriptional	O
activity	O
of	O
IL-1alpha	B-DNA
promoter-CAT	I-DNA
constructs	I-DNA
,	O
but	O
was	O
rescued	O
by	O
exogenous	O
provision	O
of	O
p65/p50	B-protein
NF-kappaB	B-protein
.	O

We	O
found	O
that	O
two	O
IL-1alpha	B-DNA
kappaB-like	I-DNA
sites	I-DNA
(	O
positions	O
-1	B-DNA
,	I-DNA
065	I-DNA
to	I-DNA
-1	I-DNA
,	I-DNA
056	I-DNA
and	O
+646	B-DNA
to	I-DNA
+655	I-DNA
)	O
specifically	O
formed	O
a	O
complex	O
with	O
NF-kappaB	B-protein
-containing	O
nuclear	O
extract	O
from	O
MT-2	B-cell_line
cells	I-cell_line
and	O
that	O
NF-kappaB	B-protein
bound	O
with	O
higher	O
affinity	O
to	O
the	O
3	B-DNA
'	I-DNA
NF-kappaB	I-DNA
binding	I-DNA
site	I-DNA
than	O
to	O
the	O
5	B-DNA
'	I-DNA
NF-kappaB	I-DNA
site	I-DNA
.	O

Moreover	O
,	O
deletion	O
of	O
either	O
5	B-DNA
'	I-DNA
or	I-DNA
3	I-DNA
'	I-DNA
NF-kappaB	I-DNA
sites	I-DNA
reduced	O
IL-1alpha	B-DNA
promoter	I-DNA
activity	O
in	O
MT-2	B-cell_line
cells	I-cell_line
and	O
transactivation	O
of	O
the	O
IL-1alpha	B-DNA
promoter	I-DNA
by	O
exogenous	O
NF-kappaB	B-protein
and	O
Tax	B-protein
in	O
Jurkat	B-cell_line
cells	I-cell_line
.	O

These	O
data	O
suggest	O
a	O
general	O
role	O
for	O
Tax	B-protein
induction	O
of	O
IL-1alpha	B-DNA
gene	I-DNA
transcription	O
by	O
the	O
NF-kappaB	B-protein
pathway	O
.	O

Expression	O
of	O
IL-1alpha	B-protein
by	O
HTLV-I	O
productively	O
infected	B-cell_type
cells	I-cell_type
may	O
be	O
important	O
in	O
the	O
hypercalcemia	O
,	O
osteolytic	O
bone	O
lesions	O
,	O
neutrophilia	O
,	O
elevation	O
of	O
C-reactive	B-protein
protein	I-protein
,	O
and	O
fever	O
frequently	O
seen	O
in	O
patients	O
with	O
HTLV-I-induced	O
adult	O
T-cell	O
leukemia/lymphoma	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
Interleukin-la	NULL
Promoter	NULL
by	NULL
Human	NULL
T-Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
I	NULL
and	NULL
Type	NULL
II	NULL
Tax	NULL
Proteins	NULL
By	NULL
Naoki	NULL
Mori	NULL
and	NULL
Diane	NULL
Prager	NULL
Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
|	NULL
(	NULL
HTLV-l	NULL
)	NULL
}	NULL
-infected	NULL
T-cell	NULL
lines	NULL
constitutively	NULL
produce	NULL
high	NULL
levels	NULL
of	NULL
interleukin-1a	NULL
(	NULL
IL-1a	NULL
}	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
mechanisms	NULL
that	NULL
lead	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
IL-1a	NULL
«	NULL
in	NULL
HTLV	NULL
--	NULL
infected	NULL
cell	NULL
lines	NULL
,	NULL
we	NULL
studied	NULL
regulatory	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
IL-1	NULL
«	NULL
promoter	NULL
involved	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
IL-1a	NULL
gene	NULL
.	NULL

IL-1a	NULL
promoter	NULL
constructs	NULL
drive	NULL
transcription	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
gene	NULL
in	NULL
HTLV-I~positive	NULL
MT-2	NULL
cells	NULL
,	NULL
which	NULL
constitutively	NULL
produce	NULL
IL-1a	NULL
.	NULL

In	NULL
a	NULL
cotransfection	NULL
assay	NULL
,	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
both	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
specifically	NULL
activated	NULL
transcription	NULL
from	NULL
the	NULL
IL-1a	NULL
promoter	NULL
in	NULL
an	NULL
uninfected	NULL
Jurkat	NULL
cell	NULL
line	NULL
.	NULL

A	NULL
mutant	NULL
Tax	NULL
protein	NULL
deficient	NULL
in	NULL
transactivation	NULL
of	NULL
genes	NULL
by	NULL
the	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-xB	NULL
pathway	NULL
was	NULL
unable	NULL
to	NULL
induce	NULL
transcriptional	NULL
activity	NULL
of	NULL
IL-1	NULL
@	NULL
promoter-CAT	NULL
constructs	NULL
,	NULL
but	NULL
was	NULL
rescued	NULL
by	NULL
exogenous	NULL
provision	NULL
of	NULL
p65/p50	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

We	NULL
DULT	NULL
T-CELL	NULL
leukemia/lymphoma	NULL
(	NULL
ATLL	NULL
)	NULL
is	NULL
one	NULL
of	NULL
the	NULL
peripheral	NULL
T-cell	NULL
malignant	NULL
neoplasms	NULL
strongly	NULL
associated	NULL
with	NULL
a	NULL
retrovirus	NULL
,	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type-I	NULL
(	NULL
HTLV-D.	NULL
'	NULL
``	NULL
ATLL	NULL
is	NULL
characterized	NULL
by	NULL
high	NULL
white	NULL
blood	NULL
cell	NULL
counts	NULL
with	NULL
convoluted	NULL
nuclei	NULL
,	NULL
hepatosplenomegaly	NULL
,	NULL
lymphadenopathy	NULL
,	NULL
skin	NULL
lesions	NULL
,	NULL
frequently	NULL
hypercalcemia	NULL
,	NULL
and	NULL
a	NULL
rapidly	NULL
progressive	NULL
terminal	NULL
course	NULL
.	NULL
``	NULL

''	NULL
Interleukin-1a	NULL
@	NULL
(	NULL
IL-1	NULL
@	NULL
)	NULL
is	NULL
not	NULL
expressed	NULL
by	NULL
resting	NULL
T	NULL
lymphocytes	NULL
and	NULL
T-cell	NULL
lines	NULL
not	NULL
infected	NULL
by	NULL
HTLV-II	NULL
such	NULL
as	NULL
the	NULL
Jurkat	NULL
cell	NULL
line	NULL
.	NULL

Several	NULL
investigators	NULL
have	NULL
reported	NULL
that	NULL
HTLV-I-infected	NULL
T-cell	NULL
lines	NULL
and	NULL
leukemic	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
ATLL	NULL
aberrantly	NULL
express	NULL
IL-la	NULL
mRNA	NULL
.	NULL

``	NULL
*	NULL
HTLV	NULL
T	NULL
cells	NULL
constitutively	NULL
secrete	NULL
this	NULL
cytokine	NULL
into	NULL
the	NULL
conditioned	NULL
medium	NULL
of	NULL
cell	NULL
lines	NULL
and	NULL
leukemic	NULL
cells	NULL
from	NULL
ATLL	NULL
patients	NULL
.	NULL
``	NULL

''	NULL
IL-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
act	NULL
as	NULL
a	NULL
potent	NULL
osteoclast-activat-ing	NULL
factor	NULL
and	NULL
to	NULL
cause	NULL
the	NULL
bone	NULL
resorption	NULL
.	NULL
``	NULL

IL-1	NULL
can	NULL
also	NULL
produce	NULL
neutrophilia	NULL
,	NULL
acute	NULL
inflammatory	NULL
protein	NULL
secretion	NULL
by	NULL
hepatocytes	NULL
,	NULL
and	NULL
fever	NULL
in	NULL
vivo	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
Many	NULL
of	NULL
these	NULL
phenomena	NULL
are	NULL
also	NULL
frequently	NULL
associated	NULL
with	NULL
ATLL	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
IL-1	NULL
activation	NULL
during	NULL
HTLV-I	NULL
infection	NULL
contributes	NULL
to	NULL
these	NULL
phenomena	NULL
and	NULL
clinical	NULL
symptoms	NULL
.	NULL

Despite	NULL
the	NULL
wealth	NULL
of	NULL
information	NULL
regarding	NULL
the	NULL
biology	NULL
of	NULL
IL-la	NULL
,	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
govern	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Division	NULL
of	NULL
Endocrinology	NULL
and	NULL
Metabolism	NULL
,	NULL
Cedars-Sinai	NULL
Medical	NULL
Center	NULL
,	NULL
UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
.	NULL

Submitted	NULL
August	NULL
14	NULL
,	NULL
1995	NULL
;	NULL
accepted	NULL
December	NULL
1	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
No	NULL
.	NULL

ROI	NULL
DK46484	NULL
.	NULL

N.M.	NULL
is	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
Cedars-Sinai	NULL
Research	NULL
Institute	NULL
Fellowship	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Naoki	NULL
Mori	NULL
,	NULL
MD	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Division	NULL
of	NULL
Endocrinology	NULL
and	NULL
Metabolism	NULL
,	NULL
Cedars-Sinai	NULL
Medical	NULL
Center	NULL
,	NULL
UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Davis	NULL
Building	NULL
3008	NULL
,	NULL
8700	NULL
Beverly	NULL
Blvd	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
90048	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
'advertisement'*	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/96/8708-0023	NULL
$	NULL
3.00/0	NULL
3410	NULL
found	NULL
that	NULL
two	NULL
IL-1a	NULL
«	NULL
B-like	NULL
sites	NULL
(	NULL
positions	NULL
-1,065	NULL
to	NULL
-1,056	NULL
and	NULL
+646	NULL
to	NULL
+655	NULL
)	NULL
specifically	NULL
formed	NULL
a	NULL
complex	NULL
with	NULL
NF-	NULL
«	NULL
B-containing	NULL
nuclear	NULL
extract	NULL
from	NULL
MT-2	NULL
cells	NULL
and	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
bound	NULL
with	NULL
higher	NULL
affinity	NULL
to	NULL
the	NULL
3	NULL
'	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
than	NULL
to	NULL
the	NULL
5°	NULL
NF-xB	NULL
site	NULL
.	NULL

Moreover	NULL
,	NULL
deletion	NULL
of	NULL
either	NULL
5	NULL
or	NULL
3	NULL
'	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
reduced	NULL
IL-1a	NULL
«	NULL
promoter	NULL
activity	NULL
in	NULL
MT-2	NULL
cells	NULL
and	NULL
transactivation	NULL
of	NULL
the	NULL
IL-1a	NULL
promoter	NULL
by	NULL
exogenous	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Tax	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
a	NULL
general	NULL
role	NULL
for	NULL
Tax	NULL
induction	NULL
of	NULL
IL-1	NULL
@	NULL
gene	NULL
transcription	NULL
by	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
.	NULL

Expression	NULL
of	NULL
IL-ia	NULL
@	NULL
by	NULL
HTLV-I	NULL
productively	NULL
infected	NULL
cells	NULL
may	NULL
be	NULL
important	NULL
in	NULL
the	NULL
hypercalcemia	NULL
,	NULL
osteolytic	NULL
bone	NULL
lesions	NULL
,	NULL
neutrophilia	NULL
,	NULL
elevation	NULL
of	NULL
C-reactive	NULL
protein	NULL
,	NULL
and	NULL
fever	NULL
frequently	NULL
seen	NULL
in	NULL
patients	NULL
with	NULL
HTLV-I-induced	NULL
adult	NULL
T-cell	NULL
leukemia/lymphoma	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

gene	NULL
in	NULL
HTLV-I-infected	NULL
T	NULL
cells	NULL
are	NULL
presently	NULL
un-clear	NULL
.	NULL

The	NULL
genomes	NULL
of	NULL
both	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
contain	NULL
sequences	NULL
at	NULL
their	NULL
3	NULL
'	NULL
end	NULL
that	NULL
encode	NULL
two	NULL
nonstructural	NULL
pro-teins	NULL
,	NULL
Tax	NULL
and	NULL
Rex	NULL
.	NULL
'	NULL

''	NULL
*	NULL
``	NULL
``	NULL
The	NULL
transactivating	NULL
Tax	NULL
proteins	NULL
of	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
function	NULL
as	NULL
an	NULL
important	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
HTLV	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
.	NULL
``	NULL

Tax	NULL
is	NULL
also	NULL
able	NULL
to	NULL
transactivate	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
genes	NULL
,	NULL
including	NULL
those	NULL
for	NULL
IL-2	NULL
,	NULL
IL-2	NULL
receptor	NULL
(	NULL
IL-2R	NULL
)	NULL
a	NULL
chain	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
IL-6	NULL
,	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
,	NULL
and	NULL
lymphotoxin	NULL
.	NULL

``	NULL
'*	NULL
``	NULL
The	NULL
regulator	NULL
of	NULL
virion	NULL
protein	NULL
expression	NULL
,	NULL
HTLV-I	NULL
Rex	NULL
,	NULL
acts	NULL
in	NULL
trans	NULL
on	NULL
viral	NULL
RNA	NULL
to	NULL
suppress	NULL
splicing	NULL
of	NULL
the	NULL
primary	NULL
transcript	NULL
.	NULL

``	NULL
*	NULL
In	NULL
addition	NULL
,	NULL
the	NULL
Rex	NULL
protein	NULL
of	NULL
HTLV-II	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
act	NULL
in	NULL
trans	NULL
to	NULL
modulate	NULL
Tax	NULL
gene-mediated	NULL
transactivation	NULL
in	NULL
a	NULL
concentration-dependent	NULL
fashion	NULL
``	NULL
and	NULL
HTLV-I	NULL
Rex	NULL
has	NULL
been	NULL
associated	NULL
with	NULL
increases	NULL
in	NULL
IL-2R	NULL
a	NULL
chain	NULL
mRNA	NULL
stability	NULL
in	NULL
HTLV-I-infected	NULL
cells	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
it	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
Tax	NULL
or	NULL
Rex	NULL
could	NULL
activate	NULL
the	NULL
IL-l	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
,	NULL
if	NULL
so	NULL
,	NULL
through	NULL
which	NULL
cis-acting	NULL
elements	NULL
it	NULL
may	NULL
act	NULL
.	NULL

At	NULL
least	NULL
four	NULL
Tax-responsive	NULL
elements	NULL
have	NULL
been	NULL
identified	NULL
:	NULL
the	NULL
21-bp	NULL
repeats	NULL
of	NULL
HTLV-I	NULL
LTR	NULL
,	NULL
the	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-	NULL
«	NULL
B	NULL
binding	NULL
motif	NULL
(	NULL
«	NULL
B	NULL
site	NULL
)	NULL
,	NULL
the	NULL
serum-response	NULL
element	NULL
,	NULL
and	NULL
the	NULL
AP-1	NULL
site	NULL
,	NULL
which	NULL
binds	NULL
members	NULL
of	NULL
the	NULL
Fos/Jun	NULL
family	NULL
.	NULL

We	NULL
recently	NULL
reported	NULL
that	NULL
HTLV-I	NULL
Tax	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
IL-1	NULL
«	NULL
gene	NULL
.	NULL
``	NULL

'	NULL
We	NULL
show	NULL
here	NULL
that	NULL
the	NULL
Tax	NULL
proteins	NULL
of	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
can	NULL
transactivate	NULL
the	NULL
human	NULL
IL-la	NULL
promoter	NULL
,	NULL
a	NULL
mechanism	NULL
that	NULL
could	NULL
explain	NULL
constitutive	NULL
IL-la	NULL
gene	NULL
expression	NULL
.	NULL

Tax	NULL
activation	NULL
of	NULL
the	NULL
IL-la	NULL
promoter	NULL
occurs	NULL
via	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
.	NULL

The	NULL
IL-la	NULL
promoter	NULL
region	NULL
required	NULL
for	NULL
Tax	NULL
activation	NULL
contains	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
and	NULL
culture	NULL
conditions	NULL
.	NULL

MT-2	NULL
``	NULL
is	NULL
an	NULL
HTLV-I-infected	NULL
T-cell	NULL
line	NULL
.	NULL

Jurkat	NULL
is	NULL
a	NULL
CD4*	NULL
T-cell	NULL
line	NULL
,	NULL
not	NULL
infected	NULL
with	NULL
HTLV-I/II	NULL
,	NULL
established	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

All	NULL
lymphoid	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
,	NULL
50	NULL
U/mL	NULL
of	NULL
penicillin	NULL
,	NULL
50	NULL
ug/	NULL
mL	NULL
of	NULL
streptomycin	NULL
,	NULL
and	NULL
L-glutamine	NULL
.	NULL

Plasmids	NULL
.	NULL

-	NULL
The	NULL
human	NULL
IL-la	NULL
constructs	NULL
«	NULL
H1	NULL
and	NULL
@	NULL
H2	NULL
are	NULL
hy-	NULL
Blood	NULL
,	NULL
Vol	NULL
87	NULL
,	NULL
No	NULL
8	NULL
(	NULL
April	NULL
15	NULL
)	NULL
,	NULL
1996	NULL
:	NULL
pp	NULL
3410-3417	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-1a	NULL
PROMOTER	NULL
TRANSACTIVATION	NULL
BY	NULL
TAX	NULL
A	NULL
S1	NULL
Al	NULL
A2	NULL
-	NULL
>	NULL
<	NULL
-	NULL
<	NULL
Hind®	NULL
|	NULL
mFoxg	NULL
Exon	NULL
1	NULL
NF-KB	NULL
Exon	NULL
2	NULL
L	NULL
r	NULL
l	NULL
~Wesbecscarece	NULL
~****	NULL
**	NULL
``	NULL
$	NULL
44	NULL
)	NULL
aH1	NULL
R	NULL
;	NULL
{	NULL
£19	NULL
aH2	NULL
cC	NULL
I	NULL
-1437	NULL
+725	NULL
50	NULL
50	NULL
MT-2	NULL
Jurkat	NULL
40	NULL
|-	NULL
40	NULL
}	NULL
fe	NULL
]	NULL
I	NULL
30	NULL
-	NULL
30	NULL
}	NULL
3	NULL
E	NULL
8	NULL
<	NULL
20	NULL
}	NULL
20	NULL
}	NULL
&	NULL
10	NULL
}	NULL
10	NULL
}	NULL
0	NULL
I-	NULL
p	NULL
iss	NULL
aH1	NULL
_	NULL
aH2	NULL
pBLCATS	NULL
aH1	NULL
_	NULL
aH2	NULL
pBLCATS	NULL
FOLD	NULL
**	NULL
26	NULL
-	NULL
1.0	NULL
_	NULL
1.0	NULL
=	NULL
Fig	NULL
1	NULL
.	NULL

IL-1a	NULL
promoter	NULL
constructs	NULL
are	NULL
active	NULL
in	NULL
MT-2	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Diagram	NULL
of	NULL
recombinant	NULL
human	NULL
IL-1	NULL
«	NULL
promoter-CAT	NULL
gene	NULL
constructs	NULL
used	NULL
for	NULL
all	NULL
transfections	NULL
.	NULL

Horizontal	NULL
arrows	NULL
indicate	NULL
the	NULL
location	NULL
and	NULL
orientation	NULL
of	NULL
the	NULL
PCR	NULL
primers	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
reporter	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
the	NULL
indicated	NULL
cell	NULL
lines	NULL
and	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
cell	NULL
extract	NULL
was	NULL
analyzed	NULL
.	NULL

The	NULL
bars	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
percentage	NULL
of	NULL
acetylation	NULL
from	NULL
three	NULL
individual	NULL
experiments	NULL
.	NULL

The	NULL
designation	NULL
of	NULL
the	NULL
different	NULL
constructs	NULL
is	NULL
given	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

The	NULL
fold	NULL
induction	NULL
for	NULL
each	NULL
was	NULL
calculated	NULL
relative	NULL
to	NULL
the	NULL
value	NULL
of	NULL
pBLCAT5	NULL
,	NULL
the	NULL
reporter	NULL
vector	NULL
without	NULL
a	NULL
promoter	NULL
insert	NULL
.	NULL

brids	NULL
of	NULL
the	NULL
human	NULL
IL-1	NULL
promoter	NULL
and	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
gene	NULL
.	NULL

«	NULL
H1	NULL
and	NULL
aH2	NULL
contain	NULL
the	NULL
IL-la	NULL
promoter	NULL
fragments	NULL
from	NULL
-1,437	NULL
to	NULL
+19	NULL
and	NULL
-1,437	NULL
to	NULL
+725	NULL
,	NULL
respectively	NULL
.	NULL

Two	NULL
promoter	NULL
fragments	NULL
were	NULL
generated	NULL
by	NULL
a	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
method	NULL
using	NULL
antisense	NULL
primers	NULL
:	NULL
Al	NULL
,	NULL
5-GGAAGATCTTCCTCTCTGGCTGGCAGCTTAAGC-3	NULL
'	NULL
(	NULL
+19	NULL
-4	NULL
)	NULL
,	NULL
and	NULL
A2	NULL
,	NULL
5-GGAAGATCTTGACTTCTGCAACAGAG-3	NULL
'	NULL
(	NULL
+725/+705	NULL
)	NULL
,	NULL
in	NULL
combination	NULL
with	NULL
a	NULL
sense	NULL
primer	NULL
;	NULL
S1	NULL
,	NULL
5	NULL
``	NULL
-CGAAG-CTTCTACCCTAGTCTGGTGCT-3	NULL
'	NULL
(	NULL
-1,437/-1,414	NULL
)	NULL
.	NULL

The	NULL
indicated	NULL
nucleotide	NULL
numbers	NULL
were	NULL
upstream	NULL
(	NULL
-	NULL
)	NULL
or	NULL
downstream	NULL
(	NULL
+	NULL
)	NULL
of	NULL
the	NULL
cap	NULL
site	NULL
,	NULL
and	NULL
location	NULL
and	NULL
orientation	NULL
of	NULL
the	NULL
primers	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
1A	NULL
.	NULL

The	NULL
underlined	NULL
sequences	NULL
were	NULL
added	NULL
to	NULL
create	NULL
Bg	NULL
!	NULL

II	NULL
sites	NULL
at	NULL
the	NULL
3	NULL
'	NULL
ends	NULL
of	NULL
PCR	NULL
products	NULL
.	NULL

The	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
Bg/	NULL
II	NULL
and	NULL
HindIII	NULL
,	NULL
a	NULL
site	NULL
that	NULL
was	NULL
located	NULL
1,437	NULL
bp	NULL
upstream	NULL
from	NULL
the	NULL
cap	NULL
site	NULL
of	NULL
the	NULL
IL-la	NULL
gene	NULL
,	NULL
and	NULL
then	NULL
ligated	NULL
to	NULL
pBLCATS	NULL
(	NULL
promoter-less	NULL
vector	NULL
)	NULL
digested	NULL
with	NULL
the	NULL
same	NULL
restriction	NULL
enzymes	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
IL-1a	NULL
promoter	NULL
CAT	NULL
construct	NULL
aH2	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
Sculptor	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
system	NULL
(	NULL
Am-ersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
a	NULL
mutagenic	NULL
oligonucleotide	NULL
3411	NULL
containing	NULL
deleted	NULL
nucleotides	NULL
was	NULL
annealed	NULL
to	NULL
the	NULL
single-stranded	NULL
DNA	NULL
template	NULL
,	NULL
followed	NULL
by	NULL
synthesis	NULL
of	NULL
the	NULL
mutant	NULL
strand	NULL
.	NULL

Mutant	NULL
plasmid	NULL
constructions	NULL
were	NULL
confirmed	NULL
by	NULL
the	NULL
dideoxy	NULL
chain	NULL
termination	NULL
method	NULL
using	NULL
Sequenase	NULL
(	NULL
US	NULL
Biochemical	NULL
Corp	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

aH2	NULL
A-1,065/-1,056	NULL
contains	NULL
a	NULL
deleted	NULL
5°	NULL
NF-KB	NULL
site	NULL
and	NULL
in	NULL
«	NULL
H2	NULL
A+646/+655	NULL
,	NULL
the	NULL
3	NULL
'	NULL
NF-kB	NULL
binding	NULL
site	NULL
was	NULL
deleted	NULL
.	NULL

The	NULL
oligonucleotides	NULL
used	NULL
for	NULL
site-directed	NULL
mutagenesis	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
A-1,065/-1,056	NULL
,	NULL
-	NULL
5'-ATAGCTGGGACTACAATCACACCT-3	NULL
'	NULL
,	NULL
and	NULL
A+646/+655	NULL
,	NULL
5	NULL
``	NULL
-GAAGCACAAAGAGGATCACAGATA-3	NULL
'	NULL
.	NULL

The	NULL
HTLV-I	NULL
Tax/Rex	NULL
expression	NULL
vector	NULL
,	NULL
BC3.9	NULL
,	NULL
``	NULL
and	NULL
HTLV-II	NULL
Tax/	NULL
Rex	NULL
expression	NULL
vector	NULL
,	NULL
BC20.2	NULL
``	NULL
are	NULL
subcloned	NULL
in	NULL
a	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
-based	NULL
vector	NULL
BCI12	NULL
,	NULL
``	NULL
°	NULL
as	NULL
described	NULL
.	NULL

BC3.9	NULL
Sph	NULL
and	NULL
BC20.2	NULL
Sph	NULL
vectors	NULL
(	NULL
Tax	NULL
only	NULL
)	NULL
lack	NULL
the	NULL
Rex	NULL
methionine	NULL
initiation	NULL
codon	NULL
.	NULL
``	NULL

Tax	NULL
A984	NULL
contains	NULL
a	NULL
30	NULL
carboxy	NULL
terminal	NULL
amino	NULL
acid	NULL
deletion	NULL
.	NULL
``	NULL

The	NULL
p50/p635	NULL
NF-	NULL
«	NULL
B	NULL
fusion	NULL
protein	NULL
expression	NULL
plasmid	NULL
was	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

The	NULL
plasmid	NULL
IL-2Ra-CAT	NULL
and	NULL
HTLV-I	NULL
were	NULL
used	NULL
to	NULL
study	NULL
the	NULL
effect	NULL
of	NULL
Tax	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
on	NULL
the	NULL
human	NULL
IL-2R	NULL
a	NULL
chain	NULL
promoter	NULL
and	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
,	NULL
respectively	NULL
.	NULL

Cell	NULL
transfection	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

_	NULL
A	NULL
Bio-Rad	NULL
Gene-Pulser	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
used	NULL
to	NULL
electroporate	NULL
cell	NULL
lines	NULL
.	NULL

MT-2	NULL
cells	NULL
(	NULL
10	NULL
cells	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
IL-1a-CAT	NULL
plasmid	NULL
in	NULL
800	NULL
LL	NULL
of	NULL
OPTI-MEM-1	NULL
medium	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
IL-la-CAT	NULL
,	NULL
IL-2Ra-CAT	NULL
,	NULL
or	NULL
HTLV-I	NULL
LTR-CAT	NULL
constructs	NULL
was	NULL
either	NULL
cotransfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
Tax	NULL
expression	NULL
plasmids	NULL
,	NULL
Tax/Rex	NULL
expression	NULL
plasmids	NULL
,	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
plasmid	NULL
in	NULL
250	NULL
gL	NULL
of	NULL
1.2	NULL
%	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
.	NULL

The	NULL
plasmid	NULL
BCI2	NULL
was	NULL
added	NULL
to	NULL
keep	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
per	NULL
sample	NULL
con-stant	NULL
.	NULL

Electroporation	NULL
conditions	NULL
were	NULL
250	NULL
V	NULL
at	NULL
a	NULL
capacitance	NULL
of	NULL
960	NULL
uF	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
repeated	NULL
at	NULL
least	NULL
three	NULL
times	NULL
with	NULL
independent	NULL
plasmid	NULL
preparations	NULL
.	NULL

After	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FBS	NULL
for	NULL
48	NULL
hours	NULL
and	NULL
then	NULL
harvested	NULL
into	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
analyzed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

To	NULL
correct	NULL
for	NULL
variation	NULL
in	NULL
cell	NULL
number	NULL
,	NULL
equal	NULL
amounts	NULL
of	NULL
cellular	NULL
protein	NULL
were	NULL
used	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
.	NULL

Reporter	NULL
gene	NULL
(	NULL
CAT	NULL
)	NULL
activity	NULL
was	NULL
analyzed	NULL
according	NULL
to	NULL
the	NULL
thin-layer	NULL
chromatography	NULL
methods	NULL
described	NULL
by	NULL
Gorman	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
The	NULL
radioactivity	NULL
of	NULL
spots	NULL
was	NULL
quantified	NULL
using	NULL
an	NULL
image	NULL
analyzer	NULL
(	NULL
AMBIS	NULL
Systems	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
acetylation	NULL
was	NULL
calculated	NULL
as	NULL
the	NULL
ratio	NULL
of	NULL
acetylated	NULL
chlorampheni-col/acetylated	NULL
+	NULL
unacetylated	NULL
chloramphenicol	NULL
.	NULL

Nuclear	NULL
extracts	NULL
preparation	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

-	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
and	NULL
MT-2	NULL
cells	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

After	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
once	NULL
in	NULL
cold	NULL
PBS	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
removed	NULL
and	NULL
the	NULL
cell	NULL
pellet	NULL
was	NULL
lysed	NULL
by	NULL
homogenization	NULL
in	NULL
hypotonic	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
1.5	NULL
mmol/L	NULL
MgCl	NULL
;	NULL
,	NULL
10	NULL
mmol/	NULL
L	NULL
KCl	NULL
,	NULL
and	NULL
0.5	NULL
mmol/L	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
)	NULL
and	NULL
centrifuged	NULL
at	NULL
1,000g	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
4°C	NULL
to	NULL
separate	NULL
the	NULL
nuclei	NULL
from	NULL
the	NULL
cytosolic	NULL
fraction	NULL
.	NULL

The	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
in	NULL
buffer	NULL
containing	NULL
20	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
15	NULL
mmol/L	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mmol/L	NULL
DTT	NULL
,	NULL
and	NULL
0.3	NULL
mol/L	NULL
KCI	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
shaking	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
centrifuged	NULL
at	NULL
13,0008	NULL
for	NULL
15	NULL
minutes	NULL
and	NULL
dia-lyzed	NULL
against	NULL
buffer	NULL
containing	NULL
20	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mol/L	NULL
KCI	NULL
,	NULL
0.2	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
and	NULL
0.5	NULL
mmol/L	NULL
DTT	NULL
for	NULL
2	NULL
hours	NULL
.	NULL

The	NULL
dialysate	NULL
was	NULL
then	NULL
centrifuged	NULL
at	NULL
13,0008	NULL
for	NULL
15	NULL
minutes	NULL
,	NULL
aliquotted	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

All	NULL
extracts	NULL
were	NULL
prepar-ated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
mmol/L	NULL
sodium	NULL
molybdate	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
.	NULL

The	NULL
nucleotide	NULL
sequences	NULL
of	NULL
oligonucleotides	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
are	NULL
as	NULL
follows	NULL
,	NULL
with	NULL
mutations	NULL
indicated	NULL
by	NULL
underlining	NULL
:	NULL
IL-l	NULL
(	NULL
-1,070/-1,051	NULL
)	NULL
,	NULL
5-aaggcTACAGGGGCATGCCATCAC-3	NULL
'	NULL
;	NULL
IL-la	NULL
(	NULL
+641/+660	NULL
)	NULL
,	NULL
5'-aagettGAGGAGGGGCTCCCCTCACA-3	NULL
``	NULL
;	NULL
IL-la	NULL
5'kB	NULL
mut	NULL
,	NULL
S-aaggCcTACATTGGCATGGAATCAC-3	NULL
'	NULL
;	NULL
IL-la	NULL
3'kB	NULL
mut	NULL
,	NULL
5'-aagcttGAGGAGGGGCTCGGATCACA-3	NULL
'	NULL
;	NULL
IL-6KB	NULL
,	NULL
5'-gatecTGGGATTTTCCCA-3	NULL
'	NULL
;	NULL
cAMP	NULL
response	NULL
element	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3412	NULL
(	NULL
CRE	NULL
)	NULL
,	NULL
5'-agetGCCTGACGTCAGAG-3	NULL
'	NULL
.	NULL

Each	NULL
oligonucleotide	NULL
was	NULL
annealed	NULL
to	NULL
its	NULL
complementary	NULL
strand	NULL
and	NULL
end-labeled	NULL
using	NULL
the	NULL
large	NULL
fragment	NULL
DNA	NULL
polymerase	NULL
(	NULL
Klenow	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
a-P	NULL
]	NULL
-dNTPs	NULL
.	NULL

The	NULL
EMSA	NULL
was	NULL
performed	NULL
as	NULL
follows	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
nuclear	NULL
extracts	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
reaction	NULL
mixture	NULL
consisting	NULL
of	NULL
20	NULL
LL	NULL
buffer	NULL
containing	NULL
10	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
50	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
for	NULL
15	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

One	NULL
microliter	NULL
of	NULL
[	NULL
&	NULL
-P	NULL
]	NULL
labeled	NULL
double-stranded	NULL
probe	NULL
(	NULL
0.5	NULL
ng	NULL
,	NULL
30,000	NULL
cpm	NULL
)	NULL
was	NULL
then	NULL
added	NULL
with	NULL
or	NULL
without	NULL
a	NULL
200-fold	NULL
excess	NULL
of	NULL
competitor	NULL
wild-type	NULL
or	NULL
mutant	NULL
oligonucleotide	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
minutes	NULL
and	NULL
run	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
%	NULL
TBE	NULL
(	NULL
1x	NULL
TBE	NULL
is	NULL
50	NULL
mmol/	NULL
L	NULL
Tris	NULL
,	NULL
50	NULL
mmol/L	NULL
boric	NULL
acid	NULL
,	NULL
and	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
for	NULL
3	NULL
hours	NULL
at	NULL
150	NULL
V	NULL
at	NULL
4°C	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
autoradiographed	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
performed	NULL
three	NULL
times	NULL
.	NULL

Results	NULL
of	NULL
a	NULL
representative	NULL
experiment	NULL
are	NULL
shown	NULL
.	NULL

RESULTS	NULL
Activity	NULL
of	NULL
IL-la	NULL
promoter	NULL
constructs	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
HTLV-I	NULL
has	NULL
an	NULL
effect	NULL
on	NULL
transcription	NULL
through	NULL
the	NULL
IL-1a	NULL
promoter	NULL
,	NULL
we	NULL
performed	NULL
studies	NULL
with	NULL
human	NULL
IL-la	NULL
promoter	NULL
constructs	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

In	NULL
MT-2	NULL
cells	NULL
,	NULL
the	NULL
transfected	NULL
CAT	NULL
gene	NULL
was	NULL
activated	NULL
when	NULL
both	NULL
fragments	NULL
of	NULL
the	NULL
IL-la	NULL
promoter	NULL
region	NULL
(	NULL
-1,437/+19	NULL
and	NULL
-1,437/	NULL
+725	NULL
)	NULL
were	NULL
inserted	NULL
into	NULL
pBLCATS	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
pBLCATS	NULL
,	NULL
the	NULL
reporter	NULL
vector	NULL
without	NULL
a	NULL
promoter	NULL
insert	NULL
,	NULL
was	NULL
not	NULL
active	NULL
.	NULL

The	NULL
larger	NULL
IL-1a	NULL
promoter	NULL
fragment	NULL
(	NULL
-1,437/	NULL
+725	NULL
)	NULL
had	NULL
approximately	NULL
twofold	NULL
greater	NULL
activity	NULL
than	NULL
did	NULL
the	NULL
smaller	NULL
fragment	NULL
(	NULL
-1,437/+	NULL
19	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
the	NULL
IL-la	NULL
promoter	NULL
constructs	NULL
are	NULL
able	NULL
to	NULL
potently	NULL
drive	NULL
transcription	NULL
of	NULL
the	NULL
heterologous	NULL
CAT	NULL
reporter	NULL
gene	NULL
in	NULL
the	NULL
MT-2	NULL
cell	NULL
line	NULL
.	NULL

To	NULL
further	NULL
elucidate	NULL
the	NULL
nature	NULL
of	NULL
HTLV-I	NULL
activation	NULL
of	NULL
the	NULL
IL-la	NULL
promoter	NULL
constructs	NULL
,	NULL
we	NULL
performed	NULL
similar	NULL
transfection	NULL
studies	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
MT-2	NULL
cells	NULL
,	NULL
both	NULL
IL-1a	NULL
sequences	NULL
tested	NULL
(	NULL
-1,437/+19	NULL
and	NULL
-1,437/	NULL
+725	NULL
)	NULL
were	NULL
not	NULL
able	NULL
to	NULL
drive	NULL
CAT	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

By	NULL
inspection	NULL
,	NULL
we	NULL
discovered	NULL
two	NULL
sequences	NULL
similar	NULL
but	NULL
not	NULL
identical	NULL
to	NULL
the	NULL
previously	NULL
identified	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
on	NULL
the	NULL
Ig	NULL
-chain	NULL
gene	NULL
(	NULL
Fig	NULL
1A	NULL
``	NULL
)	NULL
.	NULL

One	NULL
is	NULL
located	NULL
-1,065/-1,056	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
cap	NULL
site	NULL
,	NULL
and	NULL
the	NULL
other	NULL
is	NULL
located	NULL
+646/+655	NULL
bp	NULL
.	NULL

The	NULL
finding	NULL
of	NULL
putative	NULL
NF-kB	NULL
sites	NULL
was	NULL
of	NULL
interest	NULL
because	NULL
(	NULL
1	NULL
)	NULL
HTLV-I-infected	NULL
cells	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
high	NULL
levels	NULL
of	NULL
active	NULL
NF-kB	NULL
``	NULL
and	NULL
(	NULL
2	NULL
)	NULL
Tax	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
some	NULL
cellular	NULL
genes	NULL
by	NULL
causing	NULL
an	NULL
increase	NULL
in	NULL
NF-kB	NULL
levels	NULL
.	NULL
``	NULL

''	NULL
Transactivation	NULL
of	NULL
the	NULL
IL-la	NULL
promoter	NULL
by	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
results	NULL
presented	NULL
above	NULL
,	NULL
we	NULL
were	NULL
interested	NULL
in	NULL
determining	NULL
whether	NULL
HTLV	NULL
Tax	NULL
regulates	NULL
IL-la	NULL
«	NULL
promoter	NULL
expression	NULL
.	NULL

Transient	NULL
transfection	NULL
assays	NULL
were	NULL
used	NULL
to	NULL
analyze	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
transactivate	NULL
the	NULL
human	NULL
promoter	NULL
.	NULL

The	NULL
Jurkat	NULL
cell	NULL
line	NULL
was	NULL
cotransfected	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
for	NULL
either	NULL
HTLV-I	NULL
Tax	NULL
(	NULL
BC3.9	NULL
Sph	NULL
)	NULL
or	NULL
HTLV-II	NULL
Tax	NULL
(	NULL
BC20.2	NULL
Sph	NULL
)	NULL
and	NULL
CAT	NULL
reporter	NULL
vectors	NULL
containing	NULL
the	NULL
IL-l1a	NULL
promoters	NULL
.	NULL

The	NULL
reporter	NULL
containing	NULL
the	NULL
human	NULL
IL-1a	NULL
promoter	NULL
from	NULL
-1,437	NULL
to	NULL
+725	NULL
(	NULL
aH2	NULL
)	NULL
,	NULL
gave	NULL
55-	NULL
and	NULL
63-fold	NULL
induction	NULL
with	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
containing	NULL
1,456	NULL
bp	NULL
of	NULL
the	NULL
IL-1a	NULL
promoter	NULL
from	NULL
-1,437	NULL
to	NULL
+19	NULL
(	NULL
«	NULL
H1	NULL
)	NULL
MORI	NULL
AND	NULL
PRAGER	NULL
40	NULL
30	NULL
C	NULL
3	NULL
E	NULL
20	NULL
Ld	NULL
o	NULL
<	NULL
se	NULL
10	NULL
0	NULL
HTLV-I	NULL
TAX	NULL
|_	NULL
-	NULL
o	NULL
+	NULL
_-	NULL
-o	NULL
40	NULL
-	NULL
-o	NULL
40	NULL
HTLV-I	NULL
TAX	NULL
-o	NULL
0	NULL
-o	NULL
0	NULL
#	NULL
000	NULL
-	NULL
o-	NULL
ooc	NULL
to	NULL
ot	NULL
o+	NULL
#	NULL
FOLD	NULL
INDUCTION	NULL
-	NULL
8.0	NULL
14	NULL
-	NULL
0	NULL
550	NULL
63	NULL
--	NULL
1.2	NULL
1.6	NULL
L	NULL
J	NULL
ol	NULL
a	NULL
]	NULL
aH1	NULL
aH2	NULL
pBLCATS	NULL
Fig	NULL
2	NULL
.	NULL

Transactivation	NULL
of	NULL
IL-1a	NULL
CAT	NULL
promoter	NULL
constructs	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Reporter	NULL
vectors	NULL
as	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
figure	NULL
were	NULL
cotransfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
with	NULL
an	NULL
HTLV-I	NULL
Tax	NULL
(	NULL
BC3.9	NULL
Sph	NULL
)	NULL
,	NULL
an	NULL
HTLV-II	NULL
Tax	NULL
(	NULL
BC20.2	NULL
Sph	NULL
)	NULL
expression	NULL
plasmid	NULL
,	NULL
or	NULL
a	NULL
control	NULL
CMV	NULL
expression	NULL
plasmid	NULL
(	NULL
BC12	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
obtained	NULL
after	NULL
48	NULL
hours	NULL
from	NULL
transfected	NULL
cells	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Data	NULL
show	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

The	NULL
fold	NULL
induction	NULL
for	NULL
each	NULL
was	NULL
calculated	NULL
relative	NULL
to	NULL
the	NULL
value	NULL
for	NULL
the	NULL
promoter	NULL
construct	NULL
cotransfected	NULL
with	NULL
the	NULL
control	NULL
plasmid	NULL
,	NULL
BC12	NULL
.	NULL

was	NULL
also	NULL
transactivated	NULL
by	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
but	NULL
only	NULL
at	NULL
low	NULL
levels	NULL
compared	NULL
with	NULL
the	NULL
high	NULL
level	NULL
of	NULL
activation	NULL
of	NULL
aH2	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

Both	NULL
IL-la	NULL
promoter	NULL
CAT	NULL
constructs	NULL
were	NULL
similarly	NULL
transactivated	NULL
by	NULL
HTLV-I	NULL
Tax/Rex	NULL
and	NULL
HTLV-II	NULL
Tax/Rex	NULL
;	NULL
thus	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
Rex	NULL
was	NULL
not	NULL
required	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

High	NULL
level	NULL
transactivation	NULL
of	NULL
the	NULL
IL-1a	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
requires	NULL
an	NULL
intact	NULL
Tax	NULL
NF-kB	NULL
pathway	NULL
.	NULL

-	NULL
Mutant	NULL
Tax	NULL
protein	NULL
(	NULL
Tax	NULL
A984	NULL
)	NULL
contains	NULL
a	NULL
30	NULL
carboxy	NULL
terminal	NULL
amino	NULL
acid	NULL
deletion	NULL
.	NULL
``	NULL

Tax	NULL
A984	NULL
deficient	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
NF-kB	NULL
pathway	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
which	NULL
Tax	NULL
activation	NULL
pathway	NULL
was	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
IL-la	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

aHI1	NULL
or	NULL
aH2	NULL
was	NULL
cotransfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
with	NULL
either	NULL
the	NULL
wild-type	NULL
HTLV-I	NULL
Tax	NULL
expression	NULL
plasmid	NULL
,	NULL
BC3.9	NULL
Sph	NULL
,	NULL
or	NULL
a	NULL
plasmid	NULL
expressing	NULL
mutant	NULL
Tax	NULL
protein	NULL
,	NULL
Tax	NULL
A984	NULL
or	NULL
a	NULL
control	NULL
plasmid	NULL
.	NULL

BC3.9	NULL
Sph	NULL
stimulated	NULL
expression	NULL
from	NULL
aH	NULL
1	NULL
and	NULL
«	NULL
H2	NULL
sixfold	NULL
and	NULL
41	NULL
-fold	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
mutant	NULL
Tax	NULL
protein	NULL
was	NULL
unable	NULL
to	NULL
fully	NULL
transactivate	NULL
both	NULL
«	NULL
H1	NULL
and	NULL
«	NULL
H2	NULL
.	NULL

Controls	NULL
for	NULL
these	NULL
experiments	NULL
showed	NULL
that	NULL
Tax	NULL
A984	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
protein	NULL
's	NULL
ability	NULL
to	NULL
transactivate	NULL
promoters	NULL
,	NULL
such	NULL
as	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
,	NULL
whose	NULL
Tax	NULL
responsiveness	NULL
is	NULL
dependent	NULL
on	NULL
a	NULL
CRE	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Tax	NULL
A984	NULL
failed	NULL
to	NULL
transactivate	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
gene	NULL
promoter	NULL
whose	NULL
Tax-responsive	NULL
region	NULL
contains	NULL
NF-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-1	NULL
«	NULL
PROMOTER	NULL
TRANSACTIVATION	NULL
BY	NULL
TAX	NULL
30	NULL
30	NULL
aH1	NULL
aH2	NULL
§	NULL
20	NULL
|-	NULL
20	NULL
|-g	NULL
190	NULL
10F	NULL
0	NULL
0	NULL
CONT	NULL
.	NULL

HTLV-	NULL
1	NULL
TAX	NULL
|	NULL
NF-kB	NULL
CONT	NULL
.	NULL

HTLV-	NULL
1	NULL
TAX	NULL
|	NULL
NF-	NULL
«	NULL
B	NULL
TAX	NULL
_	NULL
A984	NULL
TAX	NULL
_	NULL
A984	NULL
FOLD	NULL
_	NULL
_	NULL
wDLCTION	NULL
57°	NULL
1200	NULL
64	NULL
41000	NULL
3.700	NULL
36	NULL
100	NULL
190	NULL
IL-2R	NULL
a	NULL
LTR	NULL
I	NULL
B	NULL
gsoL	NULL
so	NULL
|-	NULL
#	NULL
0	NULL
!	NULL

0	NULL
CONT	NULL
.	NULL

HTLV-	NULL
1	NULL
TAX	NULL
_	NULL
CONT	NULL
.	NULL

HTLV-I	NULL
TAX	NULL
TAX	NULL
A984	NULL
TAX	NULL
A984	NULL
FOLD	NULL
_	NULL
INDUCTION	NULL
57	NULL
1.70	NULL
153	NULL
7.0	NULL
7.9	NULL
Fig	NULL
3	NULL
.	NULL

Effect	NULL
of	NULL
a	NULL
mutant	NULL
Tax	NULL
expression	NULL
vector	NULL
on	NULL
CAT	NULL
activity	NULL
from	NULL
IL-1	NULL
,	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
,	NULL
and	NULL
HTLV-I	NULL
LTR	NULL
constructs	NULL
.	NULL

CAT	NULL
reporter	NULL
vectors	NULL
containing	NULL
the	NULL
IL-1a	NULL
promoter	NULL
,	NULL
-	NULL
1,437	NULL
to	NULL
+19	NULL
(	NULL
aH1	NULL
}	NULL
,	NULL
and	NULL
-1,437	NULL
to	NULL
+725	NULL
(	NULL
«	NULL
H2	NULL
)	NULL
were	NULL
cotransfected	NULL
together	NULL
with	NULL
HTLV-I	NULL
Tax	NULL
expression	NULL
plasmids	NULL
expressing	NULL
either	NULL
the	NULL
wild-type	NULL
protein	NULL
,	NULL
BC3.9	NULL
Sph	NULL
(	NULL
HTLV-1	NULL
TAX	NULL
)	NULL
,	NULL
a	NULL
mutant	NULL
Tax	NULL
protein	NULL
that	NULL
loses	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
the	NULL
NF-	NULL
«	NULL
B-associated	NULL
pathway	NULL
,	NULL
Tax	NULL
A984	NULL
,	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
plasmid	NULL
(	NULL
NF-B	NULL
)	NULL
,	NULL
or	NULL
a	NULL
control	NULL
plasmid	NULL
,	NULL
BC12	NULL
(	NULL
CONT	NULL
.	NULL
)	NULL

.	NULL

The	NULL
CAT	NULL
reporter	NULL
vector	NULL
containing	NULL
the	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
promoter	NULL
(	NULL
IL-2Ra	NULL
)	NULL
or	NULL
the	NULL
HTLV-I	NULL
LTR-CAT	NULL
construct	NULL
(	NULL
LTR-1	NULL
)	NULL
were	NULL
also	NULL
cotransfected	NULL
with	NULL
each	NULL
of	NULL
the	NULL
above	NULL
plasmids	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

The	NULL
fold	NULL
induction	NULL
for	NULL
each	NULL
was	NULL
calculated	NULL
relative	NULL
to	NULL
the	NULL
value	NULL
for	NULL
the	NULL
promoter	NULL
construct	NULL
cotransfected	NULL
with	NULL
the	NULL
control	NULL
plasmid	NULL
,	NULL
BC12	NULL
.	NULL

«	NULL
B	NULL
site	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Provision	NULL
of	NULL
exogenous	NULL
p65/p50	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
form	NULL
of	NULL
a	NULL
fusion	NULL
protein	NULL
stimulated	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
gene	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Cotransfection	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
plasmid	NULL
restored	NULL
full	NULL
transactivation	NULL
of	NULL
«	NULL
H1	NULL
and	NULL
«	NULL
H2	NULL
with	NULL
sixfold	NULL
and	NULL
36-fold	NULL
induction	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
,	NULL
verifying	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
high-level	NULL
activation	NULL
.	NULL

Two	NULL
promoter	NULL
NF-kB	NULL
binding	NULL
sites	NULL
specifically	NULL
bind	NULL
NF-kB-containing	NULL
nuclear	NULL
extracts	NULL
.	NULL

We	NULL
tested	NULL
nuclear	NULL
extracts	NULL
from	NULL
IL-1a-producing	NULL
cells	NULL
to	NULL
determine	NULL
whether	NULL
they	NULL
were	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
the	NULL
IL-1a	NULL
promoter	NULL
region	NULL
.	NULL

We	NULL
prepared	NULL
two	NULL
synthetic	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
NF-KB	NULL
site	NULL
and	NULL
used	NULL
them	NULL
as	NULL
probes	NULL
in	NULL
EMSA	NULL
.	NULL

We	NULL
found	NULL
that	NULL
nuclear	NULL
extracts	NULL
from	NULL
MT-2	NULL
cells	NULL
bound	NULL
to	NULL
the	NULL
IL-la	NULL
3	NULL
'	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
+641/+660	NULL
)	NULL
probe	NULL
and	NULL
,	NULL
although	NULL
less	NULL
efficiently	NULL
,	NULL
also	NULL
to	NULL
the	NULL
IL-l	NULL
5°	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
-1,070/-1,051	NULL
)	NULL
probe	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
11	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
nuclei	NULL
from	NULL
Jurkat	NULL
cells	NULL
contained	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
protein	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
3	NULL
'	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
lane	NULL
10	NULL
)	NULL
,	NULL
but	NULL
no	NULL
constitutive	NULL
binding	NULL
to	NULL
the	NULL
5°	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
was	NULL
detected	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
specificity	NULL
was	NULL
shown	NULL
by	NULL
elimination	NULL
of	NULL
this	NULL
bind	NULL
3413	NULL
ing	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
200-fold	NULL
excess	NULL
of	NULL
either	NULL
unlabeled	NULL
IL-1a	NULL
(	NULL
-1,070/-1,051	NULL
)	NULL
or	NULL
IL-1a	NULL
(	NULL
+641/+660	NULL
)	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
lanes	NULL
5	NULL
,	NULL
7	NULL
,	NULL
13	NULL
,	NULL
and	NULL
15	NULL
)	NULL
,	NULL
whereas	NULL
no	NULL
competition	NULL
was	NULL
obtained	NULL
by	NULL
an	NULL
unrelated	NULL
CRE	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
12	NULL
)	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
their	NULL
binding	NULL
was	NULL
also	NULL
eliminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
that	NULL
corresponds	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
within	NULL
the	NULL
human	NULL
IL-6	NULL
promoter	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
16	NULL
)	NULL
and	NULL
not	NULL
by	NULL
either	NULL
IL-1a	NULL
5	NULL
'	NULL
«	NULL
B	NULL
mut	NULL
or	NULL
3	NULL
'	NULL
«	NULL
B	NULL
mut	NULL
oligonucleotide	NULL
with	NULL
mutations	NULL
introduced	NULL
into	NULL
one	NULL
of	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
14	NULL
)	NULL
.	NULL

Mutant	NULL
IL-1a	NULL
3	NULL
'	NULL
«	NULL
kB	NULL
oligonucleotides	NULL
shows	NULL
no	NULL
complex	NULL
in	NULL
EMSA	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
lane	NULL
17	NULL
)	NULL
.	NULL

Competition	NULL
with	NULL
the	NULL
unlabeled	NULL
5	NULL
'	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
lane	NULL
15	NULL
)	NULL
or	NULL
3	NULL
'	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
lane	NULL
13	NULL
)	NULL
suggested	NULL
that	NULL
the	NULL
3	NULL
'	NULL
NF-KB	NULL
site	NULL
competed	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
more	NULL
efficiently	NULL
than	NULL
the	NULL
5	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
.	NULL

Thus	NULL
,	NULL
NF-kB	NULL
from	NULL
MT-2	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
we	NULL
have	NULL
shown	NULL
IL-la	NULL
promoter	NULL
activity	NULL
,	NULL
recognizes	NULL
the	NULL
two	NULL
IL-la	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
experiment	NULL
confirmed	NULL
that	NULL
the	NULL
3	NULL
'	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
+641/+660	NULL
)	NULL
binds	NULL
NF-	NULL
«	NULL
B	NULL
more	NULL
efficiently	NULL
than	NULL
the	NULL
5°	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
-1,070/-1,051	NULL
)	NULL
.	NULL

Both	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
participate	NULL
in	NULL
transactivation	NULL
by	NULL
NF-kB	NULL
or	NULL
Tax	NULL
.	NULL

-	NULL
Having	NULL
shown	NULL
that	NULL
both	NULL
NF-KB	NULL
sites	NULL
bind	NULL
NF-KB	NULL
,	NULL
albeit	NULL
with	NULL
different	NULL
efficiencies	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
the	NULL
two	NULL
sites	NULL
for	NULL
transactivation	NULL
of	NULL
the	NULL
IL-la	NULL
promoter	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
Tax	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
either	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
HTLV-I	NULL
Tax	NULL
expression	NULL
vector	NULL
together	NULL
with	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
linked	NULL
to	NULL
one	NULL
of	NULL
the	NULL
follow-ing	NULL
:	NULL
the	NULL
wild-type	NULL
IL-la	NULL
promoter	NULL
(	NULL
«	NULL
H2	NULL
,	NULL
WT	NULL
)	NULL
,	NULL
the	NULL
same	NULL
region	NULL
containing	NULL
a	NULL
deleted	NULL
5°	NULL
NF-KB	NULL
site	NULL
(	NULL
«	NULL
H2	NULL
A-1,065/	NULL
-1,056	NULL
)	NULL
or	NULL
a	NULL
deleted	NULL
3	NULL
'	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
aH2	NULL
A+646/+655	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
5B	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
5	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
had	NULL
a	NULL
moderate	NULL
effect	NULL
on	NULL
transactivation	NULL
of	NULL
IL-la	NULL
«	NULL
by	NULL
NF-kB	NULL
and	NULL
Tax	NULL
,	NULL
whereas	NULL
deletion	NULL
of	NULL
the	NULL
3	NULL
'	NULL
NF-KB	NULL
site	NULL
had	NULL
a	NULL
very	NULL
profound	NULL
effect	NULL
,	NULL
producing	NULL
an	NULL
approximately	NULL
fivefold	NULL
or	NULL
sixfold	NULL
reduction	NULL
in	NULL
IL-la	NULL
CAT	NULL
activation	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
both	NULL
NF-KB	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
efficient	NULL
transactivation	NULL
of	NULL
IL-1	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Tax	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
mutant	NULL
reporter	NULL
plasmids	NULL
aH2	NULL
A-1,065/	NULL
-1,056	NULL
or	NULL
aH2	NULL
A+646/+655	NULL
were	NULL
transfected	NULL
into	NULL
MT-2	NULL
cells	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
CAT	NULL
activity	NULL
driven	NULL
by	NULL
the	NULL
mutant	NULL
plasmids	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
aH2	NULL
construct	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
5	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
IL-1a	NULL
promoter	NULL
moderately	NULL
reduced	NULL
promoter	NULL
activity	NULL
in	NULL
MT-2	NULL
cells	NULL
,	NULL
whereas	NULL
deletion	NULL
of	NULL
the	NULL
3	NULL
'	NULL
NF-KB	NULL
site	NULL
strongly	NULL
reduced	NULL
IL-la	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
both	NULL
NF-KB	NULL
sites	NULL
are	NULL
important	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
-1,437/	NULL
+725	NULL
IL-la	NULL
promoter	NULL
fragment	NULL
.	NULL

DISCUSSION	NULL
Unlike	NULL
resting	NULL
T	NULL
lymphocytes	NULL
or	NULL
HTLV-I-uninfected	NULL
T-cell	NULL
lines	NULL
,	NULL
HTLV-I-infected	NULL
T	NULL
cells	NULL
can	NULL
constitutively	NULL
express	NULL
IL-1a	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
stimuli	NULL
.	NULL
``	NULL

However	NULL
,	NULL
very	NULL
little	NULL
is	NULL
known	NULL
concerning	NULL
the	NULL
mechanisms	NULL
that	NULL
control	NULL
IL-la	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
production	NULL
of	NULL
IL-la	NULL
is	NULL
complex	NULL
.	NULL

There	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
four	NULL
levels	NULL
of	NULL
control	NULL
:	NULL
transcription	NULL
,	NULL
mRNA	NULL
abundance	NULL
,	NULL
translation	NULL
,	NULL
and	NULL
,	NULL
finally	NULL
,	NULL
posttranslation	NULL
modification	NULL
.	NULL

Most	NULL
attention	NULL
has	NULL
been	NULL
focussed	NULL
on	NULL
regulatory	NULL
elements	NULL
responsible	NULL
for	NULL
transcriptional	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3414	NULL
MORI	NULL
AND	NULL
PRAGER	NULL
n	NULL
ao	NULL
C	NULL
y	NULL
ol	NULL
1*	NULL
&	NULL
ofl	NULL
A\	NULL
0	NULL
Probe	NULL
A	NULL
x©	NULL
``	NULL
a	NULL
G	NULL
o	NULL
g	NULL
>	NULL
V	NULL
\\	NULL
;	NULL
\	NULL
\\	NULL
``	NULL
\	NULL
I	NULL
ae	NULL
If	NULL
~	NULL
i	NULL
s=	NULL
$	NULL
i	NULL
s	NULL
f	NULL
i	NULL
5	NULL
f	NULL
s	NULL
9	NULL
o	NULL
z	NULL
$	NULL
=	NULL
2	NULL
2	NULL
£	NULL
os	NULL
u	NULL
~	NULL
w	NULL
~	NULL
m	NULL
bud	NULL
m	NULL
~	NULL
m	NULL
s	NULL
s	NULL
os	NULL
*	NULL
8	NULL
oy	NULL
s	NULL
%	NULL
woo	NULL
om	NULL
om	NULL
p	NULL
woo	NULL
t	NULL
vo	NULL
t	NULL
P	NULL
Competitor	NULL
-	NULL
-	NULL
-	NULL
§	NULL
Jo	NULL
Jl	NULL
L	NULL
L	NULL
-	NULL
-	NULL
-	NULL
§o=	NULL
J	NULL
=s	NULL
=-1	NULL
2	NULL
4	NULL
S5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
~	NULL
g	NULL
u	NULL
*	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
NF-B	NULL
binding	NULL
in	NULL
HTLV-I-infected	NULL
and	NULL
un	NULL
--	NULL
$	NULL
'	NULL
u	NULL
infected	NULL
T	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
-	NULL
14	NULL
<	NULL
-	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
10	NULL
)	NULL
or	NULL
from	NULL
MT-2	NULL
HTLV-	NULL
!	NULL

-	NULL
}	NULL
»	NULL
infected	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
3	NULL
through	NULL
8	NULL
and	NULL
11	NULL
through	NULL
I	NULL
I	NULL
17	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
extracts	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
to	NULL
[	NULL
°Pllabeled	NULL
¥	NULL
oligonucleotide	NULL
-1,070	NULL
to	NULL
-1,051	NULL
of	NULL
the	NULL
IL-1	NULL
promoter	NULL
(	NULL
lanes	NULL
1	NULL
through	NULL
8	NULL
)	NULL
,	NULL
oligonucleotide	NULL
+641	NULL
to	NULL
+660	NULL
of	NULL
the	NULL
IL-1	NULL
«	NULL
promoter	NULL
(	NULL
lanes	NULL
9	NULL
through	NULL
16	NULL
)	NULL
,	NULL
or	NULL
the	NULL
mutant	NULL
(	NULL
IL-1a	NULL
3'xB	NULL
mut	NULL
)	NULL
IL-1e	NULL
promoter	NULL
fragment	NULL
(	NULL
lane	NULL
17	NULL
)	NULL
were	NULL
analyzed	NULL
in	NULL
EMSA	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
a	NULL
200-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
CRE	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
12	NULL
)	NULL
,	NULL
IL-1	NULL
«	NULL
(	NULL
-1,070/-1,051	NULL
;	NULL
lanes	NULL
5	NULL
and	NULL
15	NULL
)	NULL
,	NULL
IL-1	NULL
«	NULL
(	NULL
+641/+660	NULL
;	NULL
lanes	NULL
7	NULL
and	NULL
13	NULL
)	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
16	NULL
)	NULL
,	NULL
IL-1a	NULL
5	NULL
'	NULL
«	NULL
B	NULL
mut	NULL
|	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
or	NULL
IL-1	NULL
3'xB	NULL
mut	NULL
(	NULL
lane	NULL
14	NULL
)	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
9	NULL
Cell	NULL
type	NULL
-	NULL
4012	NULL
?	NULL

Ary	NULL
=	NULL
Aure	NULL
Arp	NULL
contain	NULL
probes	NULL
only	NULL
.	NULL

The	NULL
arrow	NULL
marks	NULL
migration	NULL
of	NULL
C	NULL
2	NULL
%	NULL
il	NULL
the	NULL
complex	NULL
,	NULL
separated	NULL
from	NULL
the	NULL
free	NULL
probe	NULL
.	NULL

activation	NULL
.	NULL

By	NULL
analogy	NULL
with	NULL
other	NULL
cellular	NULL
genes	NULL
,	NULL
the	NULL
involvement	NULL
of	NULL
Tax	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
IL-1a	NULL
in	NULL
cells	NULL
infected	NULL
with	NULL
HTLV-I	NULL
has	NULL
been	NULL
speculated	NULL
.	NULL

We	NULL
have	NULL
presented	NULL
here	NULL
an	NULL
analysis	NULL
of	NULL
the	NULL
mechanism	NULL
of	NULL
IL-la	NULL
activation	NULL
by	NULL
concentrating	NULL
on	NULL
HTLV-I	NULL
infection	NULL
as	NULL
a	NULL
model	NULL
system	NULL
.	NULL

IL-la	NULL
promoter	NULL
constructs	NULL
were	NULL
highly	NULL
active	NULL
when	NULL
transfected	NULL
into	NULL
HTLV-I	NULL
MT-2	NULL
cells	NULL
.	NULL

These	NULL
IL-la	NULL
promoter-CAT	NULL
constructs	NULL
showed	NULL
no	NULL
significant	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Cotransfection	NULL
of	NULL
IL-la-CAT	NULL
constructs	NULL
with	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
expression	NULL
plasmids	NULL
led	NULL
to	NULL
the	NULL
detection	NULL
of	NULL
significant	NULL
promoter	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
Tax	NULL
proteins	NULL
are	NULL
directly	NULL
responsible	NULL
for	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-1a	NULL
promoter	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
Tax	NULL
can	NULL
transactivate	NULL
the	NULL
IL-la	NULL
promoter	NULL
is	NULL
one	NULL
of	NULL
the	NULL
first	NULL
cases	NULL
in	NULL
which	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
transfected	NULL
IL-la	NULL
promoter	NULL
can	NULL
be	NULL
modulated	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
(	NULL
1	NULL
)	NULL
NF-kB	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
IL-la	NULL
promoter	NULL
,	NULL
(	NULL
2	NULL
)	NULL
a	NULL
mutated	NULL
Tax	NULL
expression	NULL
vector	NULL
to	NULL
abolish	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
IL-la	NULL
promoter	NULL
,	NULL
and	NULL
(	NULL
3	NULL
)	NULL
overexpression	NULL
of	NULL
NF-kB	NULL
to	NULL
activate	NULL
IL-la	NULL
gene	NULL
expression	NULL
clearly	NULL
indicate	NULL
that	NULL
transactivation	NULL
of	NULL
the	NULL
IL-la	NULL
promoter	NULL
involves	NULL
the	NULL
DNA	NULL
binding	NULL
factor	NULL
,	NULL
NF-kB	NULL
.	NULL

We	NULL
have	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
antisense	NULL
oligodeoxynucleotides	NULL
to	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-kB	NULL
on	NULL
the	NULL
promoter	NULL
activity	NULL
and	NULL
production	NULL
of	NULL
IL-l	NULL
by	NULL
MT-2	NULL
cells	NULL
.	NULL

Exposure	NULL
to	NULL
p65	NULL
antisense	NULL
,	NULL
but	NULL
not	NULL
sense	NULL
oligodeoxynucleotides	NULL
resulted	NULL
in	NULL
inhibitions	NULL
of	NULL
IL-	NULL
la	NULL
promoter	NULL
activity	NULL
and	NULL
production	NULL
of	NULL
48	NULL
%	NULL
and	NULL
50	NULL
%	NULL
,	NULL
respectively	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
deletion	NULL
mutation	NULL
of	NULL
either	NULL
5	NULL
'	NULL
or	NULL
3	NULL
``	NULL
NF-KB	NULL
sites	NULL
of	NULL
the	NULL
IL-1	NULL
a	NULL
promoter	NULL
decreases	NULL
promoter	NULL
activity	NULL
in	NULL
MT-2	NULL
cells	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
stimulate	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
5	NULL
``	NULL
NF-KB	NULL
(	NULL
-1,065	NULL
to	NULL
-	NULL
1,056	NULL
)	NULL
and	NULL
3	NULL
``	NULL
NF-KB	NULL
(	NULL
+646	NULL
to	NULL
+655	NULL
)	NULL
sites	NULL
are	NULL
essential	NULL
for	NULL
maximal	NULL
induction	NULL
of	NULL
IL-la	NULL
transcrip-tion	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
Tax	NULL
activation	NULL
of	NULL
other	NULL
genes	NULL
such	NULL
as	NULL
IL-2R	NULL
a	NULL
chain	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
lymphotoxin	NULL
,	NULL
which	NULL
require	NULL
a	NULL
single	NULL
NF-KB	NULL
site	NULL
.	NULL
``	NULL

''	NULL
In	NULL
the	NULL
IL-1	NULL
a	NULL
gene	NULL
promoter	NULL
,	NULL
two	NULL
NF-kB	NULL
sites	NULL
exert	NULL
a	NULL
positive	NULL
regulatory	NULL
activity	NULL
and	NULL
can	NULL
function	NULL
independently	NULL
,	NULL
although	NULL
the	NULL
5°	NULL
NF-KB	NULL
site	NULL
was	NULL
demonstrably	NULL
less	NULL
important	NULL
than	NULL
the	NULL
3	NULL
'	NULL
NF-KB	NULL
site	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
IL-la	NULL
in	NULL
HTLV-I-infected	NULL
cells	NULL
suggests	NULL
the	NULL
participation	NULL
of	NULL
this	NULL
cytokine	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
HTLV-I-induced	NULL
diseases	NULL
.	NULL

Hypercalcemia	NULL
(	NULL
with	NULL
and	NULL
without	NULL
osteolytic	NULL
bone	NULL
lesions	NULL
)	NULL
is	NULL
frequently	NULL
observed	NULL
in	NULL
ATLL	NULL
patients	NULL
.	NULL

**	NULL
Several	NULL
cytokines	NULL
produced	NULL
by	NULL
HTLV-I-infected	NULL
cells	NULL
have	NULL
been	NULL
suggested	NULL
to	NULL
contribute	NULL
to	NULL
these	NULL
symptoms	NULL
.	NULL
'	NULL

''	NULL
``	NULL
°	NULL
IL-la	NULL
activates	NULL
osteoclasts	NULL
,	NULL
``	NULL
!	NULL

induces	NULL
hypercalcemia	NULL
in	NULL
mice	NULL
,	NULL
``	NULL
and	NULL
acts	NULL
synergistically	NULL
with	NULL
other	NULL
osteo-clast-activating	NULL
factors	NULL
in	NULL
bone	NULL
resorption	NULL
.	NULL
``	NULL

It	NULL
is	NULL
therefore	NULL
conceivable	NULL
that	NULL
induction	NULL
of	NULL
IL-la	NULL
by	NULL
HTLV-I	NULL
in	NULL
vivo	NULL
at	NULL
least	NULL
partially	NULL
contributes	NULL
to	NULL
the	NULL
development	NULL
of	NULL
the	NULL
osteolytic	NULL
bone	NULL
lesions	NULL
and	NULL
hypercalcemia	NULL
frequently	NULL
observed	NULL
in	NULL
ATLL	NULL
patients	NULL
.	NULL

IL-1	NULL
can	NULL
also	NULL
produce	NULL
neutrophilia	NULL
,	NULL
acute	NULL
inflammatory	NULL
protein	NULL
secretion	NULL
by	NULL
hepatocytes	NULL
,	NULL
and	NULL
fever	NULL
in	NULL
vivo	NULL
.	NULL
``	NULL

ATLL	NULL
patients	NULL
often	NULL
exhibit	NULL
neutrophilia	NULL
,	NULL
elevated	NULL
serum	NULL
levels	NULL
of	NULL
C-reactive	NULL
protein	NULL
,	NULL
and	NULL
fever	NULL
.	NULL

``	NULL
***	NULL
It	NULL
is	NULL
possible	NULL
that	NULL
ATLL	NULL
cell-derived	NULL
IL-1	NULL
may	NULL
mediate	NULL
these	NULL
responses	NULL
associated	NULL
with	NULL
ATLL	NULL
.	NULL

Another	NULL
manifestation	NULL
of	NULL
HTLV-I	NULL
infection	NULL
is	NULL
HTLV-I	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-1a	NULL
PROMOTER	NULL
TRANSACTIVATION	NULL
BY	NULL
TAX	NULL
associated	NULL
myelopathy/tropical	NULL
spastic	NULL
paraparesis	NULL
(	NULL
HAM/	NULL
TSP	NULL
)	NULL
,	NULL
a	NULL
nonneoplastic	NULL
,	NULL
immunologic	NULL
disease	NULL
of	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
(	NULL
CNS	NULL
)	NULL
.	NULL
``	NULL

In	NULL
this	NULL
disease	NULL
,	NULL
demyelination	NULL
and	NULL
inflammation	NULL
are	NULL
prominent	NULL
pathologic	NULL
features	NULL
,	NULL
but	NULL
viral	NULL
antigens	NULL
have	NULL
not	NULL
been	NULL
detected	NULL
in	NULL
CNS	NULL
tissue	NULL
.	NULL

However	NULL
,	NULL
HTLV-I	NULL
has	NULL
been	NULL
shown	NULL
in	NULL
T	NULL
cells	NULL
derived	NULL
from	NULL
the	NULL
HAM/	NULL
TSP	NULL
patient	NULL
's	NULL
cerebrospinal	NULL
fluid*	NULL
and	NULL
is	NULL
presumably	NULL
present	NULL
in	NULL
T-cell	NULL
infiltrates	NULL
in	NULL
the	NULL
brain	NULL
parenchyma	NULL
.	NULL
``	NULL

Because	NULL
T-cell	NULL
infiltration	NULL
of	NULL
the	NULL
CNS	NULL
is	NULL
a	NULL
prominent	NULL
pathologic	NULL
finding	NULL
in	NULL
HAM/TSP	NULL
,	NULL
based	NULL
on	NULL
the	NULL
present	NULL
findings	NULL
it	NULL
can	NULL
be	NULL
postulated	NULL
that	NULL
Tax	NULL
could	NULL
contribute	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
HAM/	NULL
TSP	NULL
by	NULL
stimulating	NULL
T	NULL
cells	NULL
infiltrating	NULL
HAM/TSP	NULL
lesions	NULL
to	NULL
induce	NULL
cytokine	NULL
genes	NULL
including	NULL
IL-1	NULL
,	NULL
with	NULL
associated	NULL
immune	NULL
reaction	NULL
and	NULL
inflammation	NULL
at	NULL
the	NULL
tissue	NULL
level	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
IL-ia	NULL
gene	NULL
by	NULL
Tax	NULL
could	NULL
also	NULL
have	NULL
similar	NULL
effects	NULL
in	NULL
other	NULL
tissues	NULL
because	NULL
HTLV-I	NULL
infection	NULL
has	NULL
been	NULL
associated	NULL
with	NULL
inflammatory	NULL
conditions	NULL
such	NULL
as	NULL
arthritis	NULL
,	NULL
uveitis	NULL
,	NULL
and	NULL
polymyositis	NULL
.	NULL
``	NULL

'	NULL
Extensive	NULL
clinical	NULL
studies	NULL
will	NULL
be	NULL
necessary	NULL
in	NULL
the	NULL
future	NULL
to	NULL
define	NULL
the	NULL
in	NULL
vivo	NULL
significance	NULL
of	NULL
IL-la	NULL
activation	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
and	NULL
its	NULL
participation	NULL
in	NULL
disease	NULL
processes	NULL
during	NULL
HTLV-I	NULL
infection	NULL
.	NULL

A	NULL
aH2	NULL
(	NULL
WT	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
>	NULL
€	NULL
we-	NULL
oul	NULL
aH2	NULL
a~1065/-1056	NULL
C	NULL
>	NULL
<	NULL
{	NULL
(	NULL
ar	NULL
]	NULL
aH2	NULL
A	NULL
+646/+655	NULL
B	NULL
40	NULL
[	NULL
)	NULL
cont	NULL
.	NULL

M	NULL
wees	NULL
30	NULL
3	NULL
%	NULL
x	NULL
10	NULL
0	NULL
oce	NULL
Vr\	NULL
2	NULL
t.	NULL
%	NULL
By	NULL
.	NULL

€	NULL
.	NULL

``	NULL
a	NULL
,	NULL
*	NULL
P	NULL
s	NULL
J	NULL
‘	NULL
s	NULL
)	NULL
a	NULL
0	NULL
&	NULL
9	NULL
s	NULL
Fig	NULL
5	NULL
.	NULL

-	NULL
Both	NULL
NF-xB	NULL
sites	NULL
are	NULL
necessary	NULL
for	NULL
maximal	NULL
transactivation	NULL
of	NULL
the	NULL
IL-1a	NULL
promoter	NULL
by	NULL
HTLV-l	NULL
Tax	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
IL-1	NULL
reporter	NULL
constructs	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Analysis	NULL
of	NULL
IL-1	NULL
«	NULL
promoter	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
cotransfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
BC12	NULL
reporter	NULL
plasmids	NULL
(	NULL
CONT	NULL
.	NULL
)	NULL

,	NULL
the	NULL
HTLV-I	NULL
Tax	NULL
,	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
promoter	NULL
constructs	NULL
used	NULL
were	NULL
the	NULL
wild-type	NULL
promoter	NULL
(	NULL
aH2	NULL
}	NULL
,	NULL
the	NULL
promoter	NULL
with	NULL
a	NULL
deleted	NULL
5°	NULL
NF-	NULL
«	NULL
B	NULL
element	NULL
{	NULL
aH2	NULL
1,056	NULL
)	NULL
,	NULL
or	NULL
promoter	NULL
with	NULL
a	NULL
deleted	NULL
3	NULL
'	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
aH2	NULL
A+646/+655	NULL
)	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
under	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
performed	NULL
three	NULL
times	NULL
with	NULL
the	NULL
average	NULL
values	NULL
and	NULL
SEM	NULL
bars	NULL
are	NULL
shown	NULL
.	NULL

3415	NULL
30	NULL
5	NULL
g	NULL
20	NULL
|-5	NULL
a	NULL
10	NULL
}	NULL
-	NULL
&	NULL
0	NULL
bo	NULL
3	NULL
+	NULL
,	NULL
o	NULL
,	NULL
(	NULL
C1	NULL
C	NULL
eﬂ	NULL
g	NULL
/p	NULL
R	NULL
]	NULL
(	NULL
x	NULL
0	NULL
,	NULL
5y	NULL
€	NULL
,	NULL
g.	NULL
2	NULL
3	NULL
.	NULL

0	NULL
$	NULL
63	NULL
.	NULL
)	NULL

*	NULL
)	NULL
Fig	NULL
6	NULL
.	NULL

-	NULL
Deletion	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
reduces	NULL
IL-1	NULL
«	NULL
promoter	NULL
activity	NULL
in	NULL
HTLV-l-infected	NULL
T	NULL
cells	NULL
.	NULL

MT-2	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
indicated	NULL
reporter	NULL
plasmids	NULL
for	NULL
48	NULL
hours	NULL
.	NULL

The	NULL
bars	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Poiesz	NULL
BJ	NULL
,	NULL
Ruscetti	NULL
FW	NULL
,	NULL
Gazdar	NULL
AF	NULL
,	NULL
Bunn	NULL
PA	NULL
,	NULL
Minna	NULL
JD	NULL
,	NULL
Gallo	NULL
RC	NULL
:	NULL
Detection	NULL
and	NULL
isolation	NULL
of	NULL
type	NULL
C	NULL
retrovirus	NULL
particles	NULL
from	NULL
fresh	NULL
and	NULL
cultured	NULL
lymphocytes	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
cutaneous	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
77:7415	NULL
,	NULL
1980	NULL
2	NULL
.	NULL

Yoshida	NULL
M	NULL
,	NULL
Miyoshi	NULL
I	NULL
,	NULL
Hinuma	NULL
Y	NULL
:	NULL
Isolation	NULL
and	NULL
characterization	NULL
of	NULL
retrovirus	NULL
from	NULL
cell	NULL
lines	NULL
of	NULL
human	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
and	NULL
its	NULL
implication	NULL
in	NULL
the	NULL
disease	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
79:2031	NULL
,	NULL
1982	NULL
3	NULL
.	NULL

Uchiyama	NULL
T	NULL
,	NULL
Yodoi	NULL
J	NULL
,	NULL
Sagawa	NULL
K	NULL
,	NULL
Takatsuki	NULL
K	NULL
,	NULL
Uchino	NULL
H	NULL
:	NULL
Adult	NULL
T-cell	NULL
leukemia	NULL
:	NULL
Clinical	NULL
and	NULL
hematologic	NULL
features	NULL
of	NULL
16	NULL
cases	NULL
.	NULL

Blood	NULL
50:481	NULL
,	NULL
1977	NULL
4	NULL
.	NULL

Bunn	NULL
PA	NULL
,	NULL
Schechter	NULL
GP	NULL
,	NULL
Jaffe	NULL
E	NULL
,	NULL
Blayney	NULL
D	NULL
,	NULL
Young	NULL
RC	NULL
,	NULL
Matthews	NULL
JJ	NULL
,	NULL
Blattner	NULL
W	NULL
,	NULL
Broder	NULL
S	NULL
,	NULL
Robert-Guroff	NULL
M	NULL
,	NULL
Gallo	NULL
RC	NULL
:	NULL
Clinical	NULL
course	NULL
of	NULL
retrovirus-associated	NULL
adult	NULL
T-cell	NULL
lymphoma	NULL
in	NULL
the	NULL
United	NULL
States	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
309:257	NULL
,	NULL
1983	NULL
5	NULL
.	NULL

Kinoshita	NULL
K	NULL
,	NULL
Kamihira	NULL
S	NULL
,	NULL
Ikeda	NULL
S	NULL
,	NULL
Yamada	NULL
Y	NULL
,	NULL
Muta	NULL
T	NULL
,	NULL
Kita-mura	NULL
T	NULL
,	NULL
Ichimaru	NULL
M	NULL
,	NULL
Matsuo	NULL
T	NULL
:	NULL
Clinical	NULL
,	NULL
hematologic	NULL
,	NULL
and	NULL
pathologic	NULL
features	NULL
of	NULL
leukemic	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Cancer	NULL
50:1554	NULL
,	NULL
1982	NULL
6	NULL
.	NULL

Catovski	NULL
D	NULL
,	NULL
Greaves	NULL
MF	NULL
,	NULL
Rose	NULL
M	NULL
,	NULL
Galton	NULL
DAG	NULL
,	NULL
Goolden	NULL
AWG	NULL
,	NULL
McCluskey	NULL
DR	NULL
,	NULL
White	NULL
JM	NULL
,	NULL
Lampert	NULL
I	NULL
,	NULL
Bourikas	NULL
G	NULL
,	NULL
Ireland	NULL
R	NULL
,	NULL
Brownell	NULL
Al	NULL
,	NULL
Bridges	NULL
JM	NULL
,	NULL
Blattuer	NULL
WA	NULL
,	NULL
Gallo	NULL
RC	NULL
:	NULL
Adult	NULL
T-cell	NULL
lymphoma-leukemia	NULL
in	NULL
blacks	NULL
from	NULL
the	NULL
West	NULL
Indies	NULL
.	NULL

Lancet	NULL
1:639	NULL
,	NULL
1982	NULL
7	NULL
.	NULL

Kodaka	NULL
T	NULL
,	NULL
Uchiyama	NULL
T	NULL
,	NULL
Umadome	NULL
H	NULL
,	NULL
Uchino	NULL
H	NULL
:	NULL
Expression	NULL
of	NULL
cytokine	NULL
mRNA	NULL
in	NULL
leukemic	NULL
cells	NULL
from	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
patients	NULL
.	NULL

Jpn	NULL
J	NULL
Cancer	NULL
Res	NULL
80:531	NULL
,	NULL
1989	NULL
8	NULL
.	NULL

Noma	NULL
T	NULL
,	NULL
Nakakubo	NULL
H	NULL
,	NULL
Sugita	NULL
M	NULL
,	NULL
Kumagai	NULL
S	NULL
,	NULL
Maeda	NULL
M	NULL
,	NULL
Shimizu	NULL
A	NULL
,	NULL
Honjo	NULL
T	NULL
:	NULL
Expression	NULL
of	NULL
different	NULL
combinations	NULL
of	NULL
interleu-kins	NULL
by	NULL
human	NULL
T	NULL
cell	NULL
leukemic	NULL
cell	NULL
lines	NULL
that	NULL
are	NULL
clonally	NULL
related	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
169:1853	NULL
,	NULL
1989	NULL
9	NULL
.	NULL

Wano	NULL
Y	NULL
,	NULL
Hattori	NULL
T	NULL
,	NULL
Matsuoka	NULL
M	NULL
,	NULL
Takatsuki	NULL
K	NULL
,	NULL
Chua	NULL
AO	NULL
,	NULL
Gubler	NULL
U	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Interleukin	NULL
1	NULL
gene	NULL
expression	NULL
in	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
80:911	NULL
,	NULL
1987	NULL
10	NULL
.	NULL

Shirakawa	NULL
F	NULL
,	NULL
Yamashita	NULL
U	NULL
,	NULL
Tanaka	NULL
Y	NULL
,	NULL
Watanabe	NULL
K	NULL
,	NULL
Sato	NULL
K	NULL
,	NULL
Haratake	NULL
J	NULL
,	NULL
Fujihira	NULL
T	NULL
,	NULL
Oda	NULL
S	NULL
$	NULL
,	NULL
Eto	NULL
S	NULL
;	NULL
Production	NULL
of	NULL
bone-resorbing	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3416	NULL
activity	NULL
corresponding	NULL
to	NULL
interleukin-la	NULL
by	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
cells	NULL
in	NULL
humans	NULL
.	NULL

Cancer	NULL
Res	NULL
48:4284	NULL
,	NULL
1988	NULL
11	NULL
.	NULL

Gowen	NULL
M	NULL
,	NULL
Wood	NULL
DD	NULL
,	NULL
Thrie	NULL
EJ	NULL
,	NULL
McGuire	NULL
MKB	NULL
,	NULL
Russel	NULL
RGG	NULL
:	NULL
An	NULL
interleukin	NULL
1	NULL
like	NULL
factor	NULL
stimulates	NULL
bone	NULL
resorption	NULL
in	NULL
vitro	NULL
.	NULL

Nature	NULL
306:378	NULL
,	NULL
1983	NULL
12	NULL
.	NULL

Oppenheim	NULL
JJ	NULL
,	NULL
Kovacs	NULL
EJ	NULL
,	NULL
Matsushima	NULL
K	NULL
,	NULL
Durum	NULL
SK	NULL
:	NULL
There	NULL
is	NULL
more	NULL
than	NULL
one	NULL
interleukin	NULL
1	NULL
.	NULL

Immunol	NULL
Today	NULL
7:45	NULL
,	NULL
1986	NULL
13	NULL
.	NULL

Auron	NULL
PE	NULL
,	NULL
Warner	NULL
SJC	NULL
,	NULL
Webb	NULL
AC	NULL
,	NULL
Cannon	NULL
JG	NULL
,	NULL
Bernheim	NULL
HA	NULL
,	NULL
McAdam	NULL
KJPW	NULL
,	NULL
Rosenwasser	NULL
LJ	NULL
,	NULL
LoPreste	NULL
G	NULL
,	NULL
Mucci	NULL
SF	NULL
,	NULL
Di-narello	NULL
CA	NULL
:	NULL
Studies	NULL
on	NULL
the	NULL
molecular	NULL
nature	NULL
of	NULL
human	NULL
interleukin	NULL
1	NULL
.	NULL

J	NULL
Immunol	NULL
138:1447	NULL
,	NULL
1987	NULL
14	NULL
.	NULL

Nagashima	NULL
K	NULL
,	NULL
Yoshida	NULL
M	NULL
,	NULL
Seiki	NULL
M	NULL
:	NULL
A	NULL
single	NULL
species	NULL
of	NULL
pX	NULL
mRNA	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
encodes	NULL
trans-activator	NULL
p40®	NULL
and	NULL
two	NULL
other	NULL
phosphoproteins	NULL
.	NULL

J	NULL
Virol	NULL
60:394	NULL
,	NULL
1986	NULL
15	NULL
.	NULL

Shima	NULL
H	NULL
,	NULL
Takano	NULL
M	NULL
,	NULL
Shimotohno	NULL
K	NULL
,	NULL
Miwa	NULL
M	NULL
:	NULL
Identification	NULL
of	NULL
p26Xb	NULL
and	NULL
p24Xb	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
IL	NULL
FEBS	NULL
Lett	NULL
209:289	NULL
,	NULL
1986	NULL
16	NULL
.	NULL

Shimotohno	NULL
K	NULL
,	NULL
Takahashi	NULL
Y	NULL
,	NULL
Shimizu	NULL
N	NULL
,	NULL
Gojobori	NULL
T	NULL
,	NULL
Golde	NULL
DW	NULL
,	NULL
Chen	NULL
ISY	NULL
,	NULL
Miwa	NULL
M	NULL
,	NULL
Sugimura	NULL
T	NULL
:	NULL
Complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
an	NULL
infectious	NULL
clone	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
II	NULL
:	NULL
An	NULL
open	NULL
reading	NULL
frame	NULL
for	NULL
the	NULL
protease	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
82:3101	NULL
,	NULL
1985	NULL
17	NULL
.	NULL

Slamon	NULL
DJ	NULL
,	NULL
Shimotohno	NULL
K	NULL
,	NULL
Cline	NULL
MJ	NULL
,	NULL
Golde	NULL
DW	NULL
,	NULL
Chen	NULL
ISY	NULL
:	NULL
Identification	NULL
of	NULL
the	NULL
putative	NULL
transforming	NULL
protein	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
viruses	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
.	NULL

Science	NULL
226:61	NULL
,	NULL
1984	NULL
18	NULL
.	NULL

Sodroski	NULL
J	NULL
,	NULL
Rosen	NULL
C	NULL
,	NULL
Goh	NULL
WC	NULL
,	NULL
Haseltine	NULL
W	NULL
:	NULL
A	NULL
transcriptional	NULL
activator	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
x-lor	NULL
region	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Science	NULL
228:1430	NULL
,	NULL
1985	NULL
19	NULL
.	NULL

Sodroski	NULL
JG	NULL
,	NULL
Rosen	NULL
CA	NULL
,	NULL
Haseltine	NULL
WA	NULL
:	NULL
Trans-acting	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T	NULL
lymphotropic	NULL
viruses	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

Science	NULL
225:381	NULL
,	NULL
1984	NULL
20	NULL
.	NULL

Seiki	NULL
M	NULL
,	NULL
Inoue	NULL
J	NULL
,	NULL
Takeda	NULL
T	NULL
,	NULL
Yoshida	NULL
M	NULL
:	NULL
Direct	NULL
evidence	NULL
that	NULL
p40*	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
is	NULL
a	NULL
transacting	NULL
transcriptional	NULL
activator	NULL
.	NULL

EMBO	NULL
J	NULL
5:561	NULL
,	NULL
1986	NULL
21	NULL
.	NULL

Maruyama	NULL
M	NULL
,	NULL
Shibuya	NULL
H	NULL
,	NULL
Harada	NULL
H	NULL
,	NULL
Hatakeyama	NULL
M	NULL
,	NULL
Seiki	NULL
M	NULL
,	NULL
Fujita	NULL
T	NULL
,	NULL
Inoue	NULL
J	NULL
,	NULL
Yoshida	NULL
M	NULL
,	NULL
Taniguchi	NULL
T	NULL
:	NULL
Evidence	NULL
for	NULL
aberrant	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
autocrine	NULL
loop	NULL
by	NULL
HTLV-1	NULL
encoded	NULL
p40*	NULL
and	NULL
T3/Ti	NULL
complex	NULL
triggering	NULL
.	NULL

Cell	NULL
48:343	NULL
,	NULL
1987	NULL
22	NULL
.	NULL

Siekevitz	NULL
M	NULL
,	NULL
Feinberg	NULL
M	NULL
,	NULL
Holbrook	NULL
N	NULL
,	NULL
Wong-Staal	NULL
F	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Activation	NULL
of	NULL
interleukin	NULL
2	NULL
and	NULL
interleukin	NULL
2	NULL
receptor	NULL
(	NULL
tac	NULL
)	NULL
promoter	NULL
expression	NULL
by	NULL
the	NULL
transactivator	NULL
(	NULL
tat	NULL
)	NULL
gene	NULL
product	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
,	NULL
type	NULL
1	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
84:5389	NULL
,	NULL
1987	NULL
23	NULL
.	NULL

Leung	NULL
K	NULL
,	NULL
Nabel	NULL
GJ	NULL
:	NULL
HTLV-1	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
.	NULL

Nature	NULL
333:776	NULL
,	NULL
1988	NULL
24	NULL
.	NULL

Miyatake	NULL
S	NULL
,	NULL
Seiki	NULL
M	NULL
,	NULL
Yoshida	NULL
M	NULL
,	NULL
Arai	NULL
K	NULL
:	NULL
T-cell	NULL
activation	NULL
signals	NULL
and	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I-encoded	NULL
p40*	NULL
protein	NULL
activate	NULL
the	NULL
mouse	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
through	NULL
a	NULL
common	NULL
DNA	NULL
element	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
8:5581	NULL
,	NULL
1988	NULL
25	NULL
.	NULL

Mori	NULL
N	NULL
,	NULL
Shirakawa	NULL
F	NULL
,	NULL
Shimizu	NULL
H	NULL
,	NULL
Murakami	NULL
S	NULL
,	NULL
Oda	NULL
S	NULL
,	NULL
Yamamoto	NULL
K	NULL
,	NULL
Eto	NULL
S	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
interleukin-6	NULL
gene	NULL
promoter	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I-infected	NULL
T-cell	NULL
lines	NULL
:	NULL
Evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
NF-kB	NULL
.	NULL

Blood	NULL
84:2904	NULL
,	NULL
1994	NULL
26	NULL
.	NULL

Ejima	NULL
E	NULL
,	NULL
Rosenblatt	NULL
JD	NULL
,	NULL
Massari	NULL
M	NULL
,	NULL
Quan	NULL
E	NULL
,	NULL
Stephens	NULL
D	NULL
,	NULL
Rosen	NULL
CA	NULL
,	NULL
Prager	NULL
D	NULL
:	NULL
Cell-type-specific	NULL
transactivation	NULL
of	NULL
the	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
gene	NULL
promoter	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type-I	NULL
(	NULL
HTLV-I	NULL
)	NULL
Tax	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
proteins	NULL
.	NULL

Blood	NULL
81:1017	NULL
,	NULL
1993	NULL
27	NULL
.	NULL

Tschachler	NULL
E	NULL
,	NULL
Bohnlein	NULL
E	NULL
,	NULL
Felzmann	NULL
S	NULL
,	NULL
Reitz	NULL
MS	NULL
Jr	NULL
:	NULL
Human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
lymphotoxin	NULL
gene	NULL
.	NULL

Blood	NULL
81:95	NULL
,	NULL
1993	NULL
28	NULL
.	NULL

Inoue	NULL
J	NULL
,	NULL
Yoshida	NULL
M	NULL
,	NULL
Seiki	NULL
M	NULL
:	NULL
Transcriptional	NULL
(	NULL
p40®	NULL
)	NULL
and	NULL
MORI	NULL
AND	NULL
PRAGER	NULL
post-transcriptional	NULL
(	NULL
p27*	NULL
``	NULL
``	NULL
)	NULL
regulators	NULL
are	NULL
required	NULL
for	NULL
the	NULL
expression	NULL
and	NULL
replication	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
genes	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
84:3653	NULL
,	NULL
1987	NULL
29	NULL
.	NULL

Rosenblatt	NULL
JD	NULL
,	NULL
Cann	NULL
AJ	NULL
,	NULL
Slamon	NULL
DJ	NULL
,	NULL
Smalberg	NULL
IS	NULL
,	NULL
Shah	NULL
NP	NULL
,	NULL
Fujii	NULL
J	NULL
,	NULL
Wachsman	NULL
W	NULL
,	NULL
Chen	NULL
ISY	NULL
:	NULL
HTLV-II	NULL
transactivation	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
overlapping	NULL
tax/rex	NULL
nonstructural	NULL
genes	NULL
.	NULL

Science	NULL
240.916	NULL
,	NULL
1988	NULL
30	NULL
.	NULL

Kanamori	NULL
H	NULL
,	NULL
Suzuki	NULL
N	NULL
,	NULL
Siomi	NULL
H	NULL
,	NULL
Nosaka	NULL
T	NULL
,	NULL
Sato	NULL
A	NULL
,	NULL
Sabe	NULL
H	NULL
,	NULL
Hatanaka	NULL
M	NULL
,	NULL
Honjo	NULL
T	NULL
:	NULL
HTLV-1	NULL
p27	NULL
``	NULL
*	NULL
stabilizes	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
chain	NULL
mRNA	NULL
.	NULL

EMBO	NULL
J	NULL
9:4161	NULL
,	NULL
1990	NULL
31	NULL
.	NULL

Mori	NULL
N	NULL
,	NULL
Shirakawa	NULL
F	NULL
,	NULL
Saito	NULL
K	NULL
,	NULL
Murakami	NULL
S	NULL
,	NULL
Oda	NULL
S	NULL
,	NULL
Eto	NULL
S	NULL
:	NULL
Transactivation	NULL
of	NULL
the	NULL
interleukin-la	NULL
gene	NULL
promoter	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Blood	NULL
84:1688	NULL
,	NULL
1994	NULL
32	NULL
.	NULL

Miyoshi	NULL
I	NULL
,	NULL
Kubonishi	NULL
I	NULL
,	NULL
Yoshimoto	NULL
S	NULL
,	NULL
Akagi	NULL
T	NULL
,	NULL
Ohtsuki	NULL
Y	NULL
,	NULL
Shiraishi	NULL
Y	NULL
,	NULL
Nagata	NULL
K	NULL
,	NULL
Hinuma	NULL
Y	NULL
:	NULL
Type	NULL
C	NULL
virus	NULL
particles	NULL
in	NULL
a	NULL
cord	NULL
T-cell	NULL
line	NULL
derived	NULL
by	NULL
co-cultivating	NULL
normal	NULL
human	NULL
cord	NULL
leukocytes	NULL
and	NULL
human	NULL
leukaemic	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
294:770	NULL
,	NULL
1981	NULL
33	NULL
.	NULL

Ruben	NULL
SM	NULL
,	NULL
Perkins	NULL
A	NULL
,	NULL
Rosen	NULL
CA	NULL
:	NULL
Activation	NULL
of	NULL
NF-kB	NULL
by	NULL
the	NULL
HTLV-I	NULL
trans-activator	NULL
protein	NULL
tax	NULL
requires	NULL
an	NULL
additional	NULL
factor	NULL
present	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

New	NULL
Biol	NULL
1:275	NULL
,	NULL
1989	NULL
34	NULL
.	NULL

Ruben	NULL
SM	NULL
,	NULL
Narayanan	NULL
R	NULL
,	NULL
Klement	NULL
JF	NULL
,	NULL
Chen	NULL
C-H	NULL
,	NULL
Rosen	NULL
CA	NULL
:	NULL
Functional	NULL
characterization	NULL
of	NULL
the	NULL
NFxB	NULL
p65	NULL
transcriptional	NULL
activator	NULL
and	NULL
an	NULL
alternatively	NULL
spliced	NULL
derivative	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
12:444	NULL
,	NULL
1992	NULL
35	NULL
.	NULL

Kronke	NULL
M	NULL
,	NULL
Leonard	NULL
WJ	NULL
,	NULL
Depper	NULL
JM	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Deregulation	NULL
of	NULL
interleukin-2	NULL
receptor	NULL
gene	NULL
expression	NULL
in	NULL
HTLV-I-induced	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Science	NULL
228:1215	NULL
,	NULL
1985	NULL
36	NULL
.	NULL

Gorman	NULL
CM	NULL
,	NULL
Moffat	NULL
LF	NULL
,	NULL
Howard	NULL
BH	NULL
:	NULL
Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyltransferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
2:1044	NULL
,	NULL
1982	NULL
37	NULL
.	NULL

Prager	NULL
D	NULL
,	NULL
Gerbremedhin	NULL
S	NULL
,	NULL
Melmed	NULL
S	NULL
:	NULL
An	NULL
insulin-induced	NULL
DNA-binding	NULL
protein	NULL
for	NULL
the	NULL
human	NULL
growth	NULL
hormone	NULL
gene	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
85:1680	NULL
,	NULL
1990	NULL
38	NULL
.	NULL

Lenardo	NULL
MJ	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227	NULL
,	NULL
1989	NULL
39	NULL
.	NULL

Cross	NULL
SL	NULL
,	NULL
Halden	NULL
NF	NULL
,	NULL
Lenardo	NULL
MJ	NULL
,	NULL
Leonard	NULL
WJ	NULL
:	NULL
Functionally	NULL
distinct	NULL
NFB	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
immunoglobulin	NULL
x	NULL
and	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
genes	NULL
.	NULL

Science	NULL
244:466	NULL
,	NULL
1989	NULL
40	NULL
.	NULL

Ballard	NULL
DW	NULL
,	NULL
Bohnlein	NULL
E	NULL
,	NULL
Lowenthal	NULL
JW	NULL
,	NULL
Wano	NULL
Y	NULL
,	NULL
Franza	NULL
BR	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
HTLV-I	NULL
Tax	NULL
induces	NULL
cellular	NULL
proteins	NULL
that	NULL
activate	NULL
the	NULL
xB	NULL
element	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
a	NULL
gene	NULL
.	NULL

Science	NULL
241:1652	NULL
,	NULL
1988	NULL
41	NULL
.	NULL

Ruben	NULL
S	NULL
,	NULL
Poteat	NULL
H	NULL
,	NULL
Tan	NULL
T-H	NULL
,	NULL
Kawakami	NULL
K	NULL
,	NULL
Roeder	NULL
R	NULL
,	NULL
Haseltine	NULL
W	NULL
,	NULL
Rosen	NULL
CA	NULL
:	NULL
Cellular	NULL
transcription	NULL
factors	NULL
and	NULL
regulation	NULL
of	NULL
IL-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
HTLV-I	NULL
tax	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
241:89	NULL
,	NULL
1988	NULL
42	NULL
.	NULL

Shibuya	NULL
H	NULL
,	NULL
Yoneyama	NULL
M	NULL
,	NULL
Taniguchi	NULL
T	NULL
:	NULL
Involvement	NULL
of	NULL
a	NULL
common	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
regulated	NULL
expression	NULL
of	NULL
IL-2	NULL
and	NULL
IL-2	NULL
receptor	NULL
genes	NULL
.	NULL

Int	NULL
Immunol	NULL
1:43	NULL
,	NULL
1989	NULL
43	NULL
.	NULL

Sabatini	NULL
M	NULL
,	NULL
Boyce	NULL
B	NULL
,	NULL
Aufdemorte	NULL
T	NULL
,	NULL
Bonewald	NULL
L	NULL
,	NULL
Mundy	NULL
GR	NULL
:	NULL
Infusions	NULL
of	NULL
recombinant	NULL
human	NULL
interleukin	NULL
la	NULL
and	NULL
12	NULL
cause	NULL
hypercalcemia	NULL
in	NULL
normal	NULL
mice	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:5235	NULL
,	NULL
1988	NULL
44	NULL
.	NULL

Staschenko	NULL
P	NULL
,	NULL
Dewhirst	NULL
FE	NULL
,	NULL
Peros	NULL
WJ	NULL
,	NULL
Kent	NULL
RL	NULL
,	NULL
Ago	NULL
JM	NULL
:	NULL
Synergistic	NULL
interactions	NULL
between	NULL
interleukin	NULL
1	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
and	NULL
lymphotoxin	NULL
in	NULL
bone	NULL
resorption	NULL
.	NULL

J	NULL
Immunol	NULL
138:1464	NULL
,	NULL
1987	NULL
45	NULL
.	NULL

Sato	NULL
K	NULL
,	NULL
Fujii	NULL
Y	NULL
,	NULL
Kasono	NULL
K	NULL
,	NULL
Ozawa	NULL
M	NULL
,	NULL
Imamura	NULL
H	NULL
,	NULL
Kanaji	NULL
Y	NULL
,	NULL
Kurosawa	NULL
H	NULL
,	NULL
Tsushima	NULL
T	NULL
,	NULL
Shizume	NULL
K	NULL
:	NULL
Parathyroid	NULL
hormone-related	NULL
protein	NULL
and	NULL
interleukin-la	NULL
synergistically	NULL
stimulate	NULL
bone	NULL
resorption	NULL
in	NULL
vitro	NULL
and	NULL
increase	NULL
the	NULL
serum	NULL
calcium	NULL
concentration	NULL
in	NULL
vivo	NULL
.	NULL

Endocrinology	NULL
124:2172	NULL
,	NULL
1989	NULL
46	NULL
.	NULL

Yamamoto	NULL
S	NULL
,	NULL
Hattori	NULL
T	NULL
,	NULL
Asou	NULL
N	NULL
,	NULL
Nishimura	NULL
H	NULL
,	NULL
Kawano	NULL
F	NULL
,	NULL
Yodoi	NULL
J	NULL
,	NULL
Takatsuki	NULL
K	NULL
:	NULL
Absolute	NULL
neutrophilia	NULL
in	NULL
Adult	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

Jpn	NULL
J	NULL
Cancer	NULL
Res	NULL
77:858	NULL
,	NULL
1986	NULL
47	NULL
.	NULL

Gessain	NULL
A	NULL
,	NULL
Barin	NULL
F	NULL
,	NULL
Vernant	NULL
JC	NULL
,	NULL
Gout	NULL
O	NULL
,	NULL
Maurs	NULL
L	NULL
,	NULL
Calender	NULL
A	NULL
,	NULL
de	NULL
The	NULL
G	NULL
:	NULL
Antibodies	NULL
to	NULL
human	NULL
T	NULL
lymphotrophic	NULL
virus	NULL
type-I	NULL
in	NULL
patients	NULL
with	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
.	NULL

Lancet	NULL
2:407	NULL
,	NULL
1985	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-1	NULL
«	NULL
PROMOTER	NULL
TRANSACTIVATION	NULL
BY	NULL
TAX	NULL
48	NULL
.	NULL

Osame	NULL
M	NULL
,	NULL
Usuku	NULL
K	NULL
,	NULL
Izumo	NULL
S	NULL
,	NULL
Hichi	NULL
N	NULL
,	NULL
Amitani	NULL
H	NULL
,	NULL
Igata	NULL
A	NULL
,	NULL
Matsumoto	NULL
M	NULL
,	NULL
Tara	NULL
M	NULL
:	NULL
HTLV-I~-associated	NULL
myelopathy	NULL
,	NULL
a	NULL
new	NULL
clinical	NULL
entity	NULL
.	NULL

Lancet	NULL
1:1031	NULL
,	NULL
1986	NULL
49	NULL
.	NULL

Jacobson	NULL
S	NULL
,	NULL
Raine	NULL
CS	NULL
,	NULL
Mingioli	NULL
ES	NULL
,	NULL
McFarlin	NULL
DE	NULL
:	NULL
Isolation	NULL
of	NULL
an	NULL
HTLV-1-like	NULL
retrovirus	NULL
from	NULL
patients	NULL
with	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
.	NULL

Nature	NULL
331:540	NULL
,	NULL
1988	NULL
50	NULL
.	NULL

Kira	NULL
J	NULL
,	NULL
Itoyama	NULL
Y	NULL
,	NULL
Koyanagi	NULL
Y	NULL
,	NULL
Tateishi	NULL
J	NULL
,	NULL
Kishikawa	NULL
M	NULL
,	NULL
3417	NULL
Akizuki	NULL
S	NULL
,	NULL
Kobayashi	NULL
I	NULL
,	NULL
Toki	NULL
N	NULL
,	NULL
Sueishi	NULL
K	NULL
,	NULL
Sato	NULL
H	NULL
,	NULL
Sakaki	NULL
Y	NULL
,	NULL
Yamamoto	NULL
N	NULL
,	NULL
Goto	NULL
I	NULL
:	NULL
Presence	NULL
of	NULL
HTLV-I	NULL
proviral	NULL
DNA	NULL
in	NULL
central	NULL
nervous	NULL
system	NULL
of	NULL
patients	NULL
with	NULL
HTLV-I-associated	NULL
myelopathy	NULL
.	NULL

Ann	NULL
Neurol	NULL
31:39	NULL
,	NULL
1992	NULL
51	NULL
.	NULL

Hollsberg	NULL
P	NULL
,	NULL
Hafler	NULL
DA	NULL
:	NULL
Pathogenesis	NULL
of	NULL
diseases	NULL
induced	NULL
by	NULL
human	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
infection	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
328:1173	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1996	NULL
87	NULL
:	NULL
2410-3417	NULL
Transactivation	NULL
of	NULL
the	NULL
interleukin-1alpha	NULL
promoter	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
Tax	NULL
proteins	NULL
N	NULL
Mori	NULL
and	NULL
D	NULL
Prager	NULL
4	NULL
,	NULL
8	NULL
5	NULL
p	NULL
'	NULL
ﬁ	NULL
'	NULL
f	NULL
)	NULL
..	NULL
os	NULL
2101	NULL
%	NULL
N	NULL
@	NULL
0	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/87/8/3410.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

